Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH5 DNAH8 DNHD1 DNAH2 DNAH1 DNAH17	2.85e-07	18	326	6	GO:0008569
GeneOntologyMolecularFunction	ATP-dependent activity	ABCA3 TMEM94 VPS4A DNAH5 DNAH8 HSPA4 DYNC1I1 RAD51C DNHD1 ATP13A1 DNAH2 ABCC5 YTHDC2 INO80 ATP9A ABCC6 DNAH1 ACSM4 DNAH17 HELZ2 DDX53 ACSM2A ATP2A1 ATP2A3 ACSM6 ATP4A ACSL5 ATP6V0A2 ACSM2B	3.37e-07	614	326	29	GO:0140657
GeneOntologyMolecularFunction	fatty-acyl-CoA synthase activity	ACSM4 ACSM2A ACSM6 ACSM2B	4.64e-06	8	326	4	GO:0004321
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH5 DNAH8 DNHD1 DNAH2 DNAH1 DNAH17	5.03e-06	28	326	6	GO:0051959
GeneOntologyMolecularFunction	decanoate-CoA ligase activity	ACSM4 ACSM2A ACSM2B	1.70e-05	4	326	3	GO:0102391
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR1 RYR2 RYR3	1.70e-05	4	326	3	GO:0005219
GeneOntologyMolecularFunction	very-low-density lipoprotein particle receptor activity	LRP8 VLDLR LDLR	1.70e-05	4	326	3	GO:0030229
GeneOntologyMolecularFunction	medium-chain fatty acid-CoA ligase activity	ACSM4 ACSM2A ACSM6 ACSM2B	2.10e-05	11	326	4	GO:0031956
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH5 DNAH8 DNHD1 DNAH2 DNAH1 DNAH17	2.74e-05	37	326	6	GO:0045505
GeneOntologyMolecularFunction	fatty acid ligase activity	ACSM4 ACSM2A ACSM6 ACSL5 ACSM2B	5.58e-05	26	326	5	GO:0015645
GeneOntologyMolecularFunction	CoA-ligase activity	ACSM4 ACSM2A ACSM6 ACSL5 ACSM2B	6.76e-05	27	326	5	GO:0016405
GeneOntologyMolecularFunction	ATPase-coupled transmembrane transporter activity	ABCA3 TMEM94 ATP13A1 ABCC5 ABCC6 ATP2A1 ATP2A3 ATP4A ATP6V0A2	7.52e-05	109	326	9	GO:0042626
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR1 RYR2 RYR3	8.31e-05	6	326	3	GO:0048763
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor activity	LRP8 VLDLR LDLR LRP1	1.09e-04	16	326	4	GO:0005041
GeneOntologyMolecularFunction	acid-thiol ligase activity	ACSM4 ACSM2A ACSM6 ACSL5 ACSM2B	1.35e-04	31	326	5	GO:0016878
GeneOntologyMolecularFunction	ligase activity	ACACB GART PFAS AARS2 TARS2 ACSM4 ACSM2A ACSM6 TTLL13 ACSL5 ACSM2B	1.41e-04	174	326	11	GO:0016874
GeneOntologyMolecularFunction	microtubule motor activity	DNAH5 DNAH8 DYNC1I1 DNHD1 DNAH2 DNAH1 DNAH17	1.44e-04	70	326	7	GO:0003777
GeneOntologyMolecularFunction	reelin receptor activity	LRP8 VLDLR	2.66e-04	2	326	2	GO:0038025
GeneOntologyMolecularFunction	apolipoprotein binding	LRP8 VLDLR MTTP LRP1	2.75e-04	20	326	4	GO:0034185
GeneOntologyMolecularFunction	P-type transmembrane transporter activity	TMEM94 ATP13A1 ATP2A1 ATP2A3 ATP4A	2.80e-04	36	326	5	GO:0140358
GeneOntologyMolecularFunction	P-type ion transporter activity	TMEM94 ATP13A1 ATP2A1 ATP2A3 ATP4A	2.80e-04	36	326	5	GO:0015662
GeneOntologyMolecularFunction	C-acyltransferase activity	ACSM4 ACSM2A ACSM6 ACSM2B	3.35e-04	21	326	4	GO:0016408
GeneOntologyMolecularFunction	lipoprotein particle receptor activity	LRP8 VLDLR LDLR LRP1	3.35e-04	21	326	4	GO:0030228
GeneOntologyMolecularFunction	ATPase-coupled monoatomic cation transmembrane transporter activity	TMEM94 ATP13A1 ATP2A1 ATP2A3 ATP4A ATP6V0A2	5.15e-04	62	326	6	GO:0019829
GeneOntologyMolecularFunction	ligase activity, forming carbon-sulfur bonds	ACSM4 ACSM2A ACSM6 ACSL5 ACSM2B	5.20e-04	41	326	5	GO:0016877
GeneOntologyMolecularFunction	benzoate-CoA ligase activity	ACSM2A ACSM2B	7.89e-04	3	326	2	GO:0018858
GeneOntologyMolecularFunction	toxin transmembrane transporter activity	SLC22A25 SLC22A9 LRP5	8.50e-04	12	326	3	GO:0019534
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	TSPOAP1 RYR1 RYR2 RYR3 PKD1 TRPV3 TRPM1 ATP2A1 ATP2A3	8.58e-04	151	326	9	GO:0015085
GeneOntologyMolecularFunction	transporter activity	GABRB1 GABRB3 GABRD SLC22A25 ABCA3 TSPOAP1 TMEM94 SLC6A19 ATG2A RYR1 RYR2 RYR3 PCTP CHRNE SLC22A6 GJD3 PKD1 TRPV3 TRPM1 SLC22A20P ATP13A1 ATG2B XKR8 ABCC5 ATP9A ABCC6 SLC5A5 SLC22A9 PIEZO2 PRF1 MTTP LRP5 ATP2A1 ATP2A3 ATP4A ATP6V0A2	1.17e-03	1289	326	36	GO:0005215
GeneOntologyMolecularFunction	lipid transporter activity	SLC22A25 ABCA3 ATG2A PCTP SLC22A6 ATG2B XKR8 ATP9A SLC22A9 MTTP	1.48e-03	196	326	10	GO:0005319
GeneOntologyMolecularFunction	calcium-dependent ATPase activity	ATP2A1 ATP2A3	1.56e-03	4	326	2	GO:0030899
GeneOntologyMolecularFunction	ABC-type xenobiotic transporter activity	ABCA3 ABCC5 ABCC6	1.70e-03	15	326	3	GO:0008559
GeneOntologyBiologicalProcess	axonemal dynein complex assembly	DNAAF8 DNAH5 DNAH8 CFAP73 DNAH2 DNAH1 DNAH17	3.14e-06	41	324	7	GO:0070286
GeneOntologyCellularComponent	dynein complex	DNAH5 DNAH8 DYNC1I1 DNHD1 DNAH2 DYNC2I1 DNAH1 DNAH17	1.92e-06	54	329	8	GO:0030286
GeneOntologyCellularComponent	axonemal dynein complex	DNAH5 DNAH8 DNHD1 DNAH2 DNAH1 DNAH17	2.00e-06	25	329	6	GO:0005858
GeneOntologyCellularComponent	microtubule associated complex	LRP8 PXN DNAH5 DNAH8 DYNC1I1 DNHD1 HAUS5 DNAH2 DYNC2I1 DNAH1 DNAH17	5.08e-05	161	329	11	GO:0005875
GeneOntologyCellularComponent	nuclear ubiquitin ligase complex	BCOR ANAPC10 CDC16 BUB1B BRCC3 CBX8	1.15e-04	49	329	6	GO:0000152
GeneOntologyCellularComponent	inner dynein arm	DNHD1 DNAH2 DNAH1	4.27e-04	10	329	3	GO:0036156
GeneOntologyCellularComponent	basolateral plasma membrane	SLC22A25 EPPK1 SLC22A6 PROM2 PKD1 ABCC5 LDLR ABCC6 SLC22A9 CD1D LPO MTTP LRP1 SCRIB	5.89e-04	320	329	14	GO:0016323
GeneOntologyCellularComponent	sarcoplasmic reticulum membrane	RYR1 RYR2 RYR3 ATP2A1 ATP2A3	6.83e-04	45	329	5	GO:0033017
GeneOntologyCellularComponent	phagophore	ATG2A ATG2B	7.33e-04	3	329	2	GO:0061908
GeneOntologyCellularComponent	outer dynein arm	DNAH5 DNAH8 DNAH17	7.65e-04	12	329	3	GO:0036157
Domain	Ldl_recept_b	LRP8 LRP5L VLDLR LDLR LRP1 LRP5	7.89e-08	14	331	6	PF00058
Domain	LDLRB	LRP8 LRP5L VLDLR LDLR LRP1 LRP5	7.89e-08	14	331	6	PS51120
Domain	LY	LRP8 LRP5L VLDLR LDLR LRP1 LRP5	1.30e-07	15	331	6	SM00135
Domain	LDLR_classB_rpt	LRP8 LRP5L VLDLR LDLR LRP1 LRP5	1.30e-07	15	331	6	IPR000033
Domain	LDLRA_1	SSPOP LRP8 PKD1 VLDLR CFI LDLR LRP1 LRP5	1.82e-06	48	331	8	PS01209
Domain	LDLRA_2	SSPOP LRP8 PKD1 VLDLR CFI LDLR LRP1 LRP5	2.14e-06	49	331	8	PS50068
Domain	MT	DNAH5 DNAH8 DNHD1 DNAH2 DNAH1	2.98e-06	14	331	5	PF12777
Domain	Dynein_HC_stalk	DNAH5 DNAH8 DNHD1 DNAH2 DNAH1	2.98e-06	14	331	5	IPR024743
Domain	Dynein_heavy_dom-2	DNAH5 DNAH8 DNHD1 DNAH2 DNAH1	2.98e-06	14	331	5	IPR013602
Domain	DHC_N2	DNAH5 DNAH8 DNHD1 DNAH2 DNAH1	2.98e-06	14	331	5	PF08393
Domain	DHC_fam	DNAH5 DNAH8 DNHD1 DNAH2 DNAH1	4.40e-06	15	331	5	IPR026983
Domain	Dynein_heavy	DNAH5 DNAH8 DNHD1 DNAH2 DNAH1	4.40e-06	15	331	5	PF03028
Domain	Dynein_heavy_dom	DNAH5 DNAH8 DNHD1 DNAH2 DNAH1	4.40e-06	15	331	5	IPR004273
Domain	-	LRP8 LRP5L VLDLR LDLR TENM4 LRP1 LRP5	4.87e-06	39	331	7	2.120.10.30
Domain	RyR	RYR1 RYR2 RYR3	5.52e-06	3	331	3	PF02026
Domain	RR_TM4-6	RYR1 RYR2 RYR3	5.52e-06	3	331	3	PF06459
Domain	Ryan_recept	RYR1 RYR2 RYR3	5.52e-06	3	331	3	IPR013333
Domain	Ryanodine_rcpt	RYR1 RYR2 RYR3	5.52e-06	3	331	3	IPR003032
Domain	Ryanrecept_TM4-6	RYR1 RYR2 RYR3	5.52e-06	3	331	3	IPR009460
Domain	LDLR_class-A_CS	SSPOP LRP8 VLDLR CFI LDLR LRP1 LRP5	5.81e-06	40	331	7	IPR023415
Domain	Ldl_recept_a	SSPOP LRP8 VLDLR CFI LDLR LRP1 LRP5	1.31e-05	45	331	7	PF00057
Domain	-	SSPOP LRP8 VLDLR CFI LDLR LRP1 LRP5	1.52e-05	46	331	7	4.10.400.10
Domain	6-blade_b-propeller_TolB-like	LRP8 LRP5L VLDLR LDLR TENM4 LRP1 LRP5	1.52e-05	46	331	7	IPR011042
Domain	LDLa	SSPOP LRP8 VLDLR CFI LDLR LRP1 LRP5	2.34e-05	49	331	7	SM00192
Domain	LDrepeatLR_classA_rpt	SSPOP LRP8 VLDLR CFI LDLR LRP1 LRP5	2.34e-05	49	331	7	IPR002172
Domain	ATPase_P-typ_transduc_dom_A	TMEM94 ATP13A1 ATP9A ATP2A1 ATP2A3 ATP4A	4.33e-05	37	331	6	IPR008250
Domain	E1-E2_ATPase	TMEM94 ATP13A1 ATP9A ATP2A1 ATP2A3 ATP4A	4.33e-05	37	331	6	PF00122
Domain	EGF_1	RELN LAMC3 SSPOP LRP8 MEP1A UMODL1 USH2A VLDLR COMP LDLR TENM4 PRF1 LRP1 LRP5 EGFL8	5.33e-05	255	331	15	PS00022
Domain	ATPase_dyneun-rel_AAA	DNAH5 DNAH8 DNAH2 DNAH1	8.43e-05	14	331	4	IPR011704
Domain	AAA_8	DNAH5 DNAH8 DNAH2 DNAH1	8.43e-05	14	331	4	PF12780
Domain	AAA_5	DNAH5 DNAH8 DNAH2 DNAH1	8.43e-05	14	331	4	PF07728
Domain	Dynein_heavy_chain_D4_dom	DNAH5 DNAH8 DNAH2 DNAH1	8.43e-05	14	331	4	IPR024317
Domain	Ryanodine_recept-rel	RYR1 RYR2 RYR3	1.06e-04	6	331	3	IPR015925
Domain	-	RYR1 RYR2 RYR3	1.06e-04	6	331	3	1.25.10.30
Domain	RIH_assoc-dom	RYR1 RYR2 RYR3	1.06e-04	6	331	3	IPR013662
Domain	Ins145_P3_rec	RYR1 RYR2 RYR3	1.06e-04	6	331	3	PF08709
Domain	RIH_assoc	RYR1 RYR2 RYR3	1.06e-04	6	331	3	PF08454
Domain	RIH_dom	RYR1 RYR2 RYR3	1.06e-04	6	331	3	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR2 RYR3	1.06e-04	6	331	3	IPR014821
Domain	RYDR_ITPR	RYR1 RYR2 RYR3	1.06e-04	6	331	3	PF01365
Domain	AMP_BINDING	ACSM4 ACSM2A ACSM6 ACSL5 ACSM2B	1.19e-04	28	331	5	PS00455
Domain	ATPase_P-typ_TM_dom	TMEM94 ATP2A1 ATP2A3 ATP4A	1.49e-04	16	331	4	IPR023298
Domain	-	TMEM94 ATP2A1 ATP2A3 ATP4A	1.49e-04	16	331	4	1.20.1110.10
Domain	EGF-like_dom	RELN LAMC3 LRP8 MEP1A UMODL1 VLDLR COMP LDLR TENM4 PRF1 PCSK6 LRP1 LRP5 EGFL8	1.52e-04	249	331	14	IPR000742
Domain	AMP-dep_Synth/Lig	ACSM4 ACSM2A ACSM6 ACSL5 ACSM2B	1.68e-04	30	331	5	IPR000873
Domain	AMP-binding	ACSM4 ACSM2A ACSM6 ACSL5 ACSM2B	1.68e-04	30	331	5	PF00501
Domain	Cation_ATPase_C	TMEM94 ATP2A1 ATP2A3 ATP4A	1.92e-04	17	331	4	PF00689
Domain	ATPase_P-typ_cation-transptr_C	TMEM94 ATP2A1 ATP2A3 ATP4A	1.92e-04	17	331	4	IPR006068
Domain	-	ATP13A1 ATP9A ATP2A1 ATP2A3 ATP4A	2.31e-04	32	331	5	3.40.1110.10
Domain	-	ATP13A1 ATP9A ATP2A1 ATP2A3 ATP4A	2.31e-04	32	331	5	2.70.150.10
Domain	EGF_2	RELN LAMC3 SSPOP LRP8 MEP1A UMODL1 VLDLR COMP LDLR TENM4 PRF1 LRP1 LRP5 EGFL8	2.88e-04	265	331	14	PS01186
Domain	DHC_N1	DNAH5 DNAH8 DNAH2	2.89e-04	8	331	3	PF08385
Domain	Dynein_heavy_dom-1	DNAH5 DNAH8 DNAH2	2.89e-04	8	331	3	IPR013594
Domain	EGF	RELN LAMC3 LRP8 MEP1A UMODL1 VLDLR COMP LDLR TENM4 PCSK6 LRP1 LRP5 EGFL8	3.04e-04	235	331	13	SM00181
Domain	EGF_3	RELN SSPOP LRP8 MEP1A UMODL1 VLDLR COMP LDLR TENM4 PRF1 LRP1 LRP5 EGFL8	3.04e-04	235	331	13	PS50026
Domain	ATG2	ATG2A ATG2B	3.13e-04	2	331	2	IPR026849
Domain	ATG2_CAD	ATG2A ATG2B	3.13e-04	2	331	2	PF13329
Domain	ATG2_CAD_motif	ATG2A ATG2B	3.13e-04	2	331	2	IPR026885
Domain	ATPase_P-typ_cyto_domN	ATP13A1 ATP9A ATP2A1 ATP2A3 ATP4A	3.56e-04	35	331	5	IPR023299
Domain	Leu-rich_rpt	LRRC45 LRFN3 LRIG2 LRRIQ1 CIITA PKD1 NLRP8 NLRP13 FLII ECM2 LRRC46 IGFALS LRRC1 SCRIB	3.61e-04	271	331	14	IPR001611
Domain	EGF_CA	LRP8 UMODL1 VLDLR COMP LDLR LRP1 LRP5 EGFL8	3.78e-04	99	331	8	PS01187
Domain	ATPase_P-typ_P_site	ATP13A1 ATP9A ATP2A1 ATP2A3 ATP4A	4.07e-04	36	331	5	IPR018303
Domain	P_typ_ATPase	ATP13A1 ATP9A ATP2A1 ATP2A3 ATP4A	4.07e-04	36	331	5	IPR001757
Domain	ATPASE_E1_E2	ATP13A1 ATP9A ATP2A1 ATP2A3 ATP4A	4.07e-04	36	331	5	PS00154
Domain	Growth_fac_rcpt_	LAMC3 IGFBPL1 LRP8 UMODL1 KAZALD1 VLDLR COMP LDLR PCSK6 LRP1	4.77e-04	156	331	10	IPR009030
Domain	MIR	RYR1 RYR2 RYR3	6.03e-04	10	331	3	PF02815
Domain	MIR_motif	RYR1 RYR2 RYR3	6.03e-04	10	331	3	IPR016093
Domain	MIR	RYR1 RYR2 RYR3	6.03e-04	10	331	3	PS50919
Domain	MIR	RYR1 RYR2 RYR3	6.03e-04	10	331	3	SM00472
Domain	-	LRRC45 LRFN3 LRIG2 FBXO38 LRRIQ1 CIITA PKD1 NLRP8 NLRP13 FLII ECM2 LRRC46 IGFALS LRRC1 SCRIB	6.45e-04	321	331	15	3.80.10.10
Domain	NACHT_NTPase	CIITA NLRP8 NLRP13 TEP1	6.57e-04	23	331	4	IPR007111
Domain	NACHT	CIITA NLRP8 NLRP13 TEP1	6.57e-04	23	331	4	PS50837
Domain	L_dom-like	LRRC45 LRFN3 LRIG2 FBXO38 LRRIQ1 CIITA PKD1 NLRP8 NLRP13 FLII ECM2 LRRC46 IGFALS LRRC1 SCRIB	8.04e-04	328	331	15	IPR032675
Domain	EGF-like_CS	RELN LAMC3 LRP8 MEP1A UMODL1 VLDLR COMP LDLR TENM4 PRF1 LRP1 LRP5 EGFL8	8.16e-04	261	331	13	IPR013032
Domain	EGF_CA	LRP8 UMODL1 VLDLR COMP LDLR LRP1 EGFL8	8.36e-04	86	331	7	PF07645
Domain	GABAAb_rcpt	GABRB1 GABRB3	9.28e-04	3	331	2	IPR002289
Domain	P-type_ATPase_IIA	ATP2A1 ATP2A3	9.28e-04	3	331	2	IPR005782
Domain	IGFBP_rP_mac25	IGFBPL1 KAZALD1	9.28e-04	3	331	2	IPR011390
Domain	AMP-binding_CS	ACSM4 ACSM2A ACSL5 ACSM2B	1.06e-03	26	331	4	IPR020845
Domain	AAA+_ATPase	ABCA3 VPS4A DNAH5 DNAH8 RAD51C DNAH2 ABCC5 ABCC6 HELZ2	1.08e-03	144	331	9	IPR003593
Domain	AAA	ABCA3 VPS4A DNAH5 DNAH8 RAD51C DNAH2 ABCC5 ABCC6 HELZ2	1.08e-03	144	331	9	SM00382
Domain	Leu-rich_rpt_typical-subtyp	LRFN3 LRIG2 LRRIQ1 PKD1 FLII ECM2 LRRC46 IGFALS LRRC1 SCRIB	1.26e-03	177	331	10	IPR003591
Domain	LRR_TYP	LRFN3 LRIG2 LRRIQ1 PKD1 FLII ECM2 LRRC46 IGFALS LRRC1 SCRIB	1.26e-03	177	331	10	SM00369
Domain	RhoGEF	FARP2 DNMBP ARHGEF6 FGD3 FGD2 ARHGEF15	1.29e-03	68	331	6	SM00325
Domain	RhoGEF	FARP2 DNMBP ARHGEF6 FGD3 FGD2 ARHGEF15	1.50e-03	70	331	6	PF00621
Domain	DH_2	FARP2 DNMBP ARHGEF6 FGD3 FGD2 ARHGEF15	1.50e-03	70	331	6	PS50010
Domain	-	FARP2 DNMBP ARHGEF6 FGD3 FGD2 ARHGEF15	1.61e-03	71	331	6	1.20.900.10
Domain	DH-domain	FARP2 DNMBP ARHGEF6 FGD3 FGD2 ARHGEF15	1.61e-03	71	331	6	IPR000219
Domain	EGF-like_Ca-bd_dom	LRP8 UMODL1 VLDLR COMP LDLR LRP1 LRP5 EGFL8	1.66e-03	124	331	8	IPR001881
Domain	EGF_Ca-bd_CS	LRP8 UMODL1 VLDLR COMP LDLR LRP1 EGFL8	1.69e-03	97	331	7	IPR018097
Domain	Spectrin_bsu	SPTBN2 SPTBN4	1.84e-03	4	331	2	IPR016343
Domain	-	GART PFAS	1.84e-03	4	331	2	3.30.1330.10
Domain	AIRS_C	GART PFAS	1.84e-03	4	331	2	PF02769
Domain	AIRS	GART PFAS	1.84e-03	4	331	2	PF00586
Domain	PurM-like_N	GART PFAS	1.84e-03	4	331	2	IPR016188
Domain	AIR_synth_C_dom	GART PFAS	1.84e-03	4	331	2	IPR010918
Domain	LRR_1	LRRC45 LRFN3 LRIG2 LRRIQ1 CIITA FLII ECM2 LRRC46 IGFALS LRRC1 SCRIB	1.89e-03	219	331	11	PF00560
Domain	Quinoprotein_ADH-like_supfam	EMC1 DMXL2 WDR36 ERN2 WDR87	2.43e-03	53	331	5	IPR011047
Domain	fn3	TSPOAP1 LRFN3 PTPRK UMODL1 CNTN5 COL14A1 USH2A CNTFR CSF3R	2.45e-03	162	331	9	PF00041
Domain	TPR_repeat	PRPF6 CDC16 TTC5 OGT TTC17 GPSM1 TTC33 LRP2BP	2.58e-03	133	331	8	IPR019734
Pathway	BIOCARTA_LIS1_PATHWAY	RELN CLIP1 LRP8 DNAH8 DNAH2 DNAH1	4.44e-07	19	234	6	M22005
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	RIN3 EPPK1 TMEM94 PFAS LAMC3 ATG2A ZZEF1 RYR1 PSME4 SBF1 PROM2 PIK3CD PKD1 PXN KAZALD1 TTC5 DNMBP D2HGDH TRAPPC9 IQCE FLII ITPRIPL2 ATP13A1 POLRMT INO80 IDUA TEP1 CDC42BPB CDC14B LDLR CCDC142 MYOF PPP1R15B HELZ2 NINL LRP5 ATP2A3	7.73e-11	1105	338	37	35748872
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	PDE3B EMC1 RPN2 USP11 UNC5B SPTBN2 PFAS PRPF6 RB1CC1 LRIG2 TRMT10C SBF1 ZNF644 BUB1B TMEM131L COL14A1 DNAJC1 PLOD1 FAM135A HSPA4 DMXL2 WDR36 DSC3 ATP13A1 POLRMT RCN2 TRIOBP TARS2 ECH1 YES1 CDC42BPB SNX29 THOC5 LGALS3BP DNAJC17 CLMN PPP1R15B LRRC1 LSS TTC17 SCRIB LAS1L ATP6V0A2	2.06e-10	1487	338	43	33957083
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	INTU PDE3B SRC CTIF SSPOP RXRA INKA2 LRP8 FARP2 PTPN4 ANAPC10 PROM2 ZNF589 PLOD1 TRAPPC9 CREB3L2 DOCK1 PRUNE2 GALNT10 TUT4 OGT TRIOBP DYNC2I1 SYT2 TARS2 TEP1 ECH1 TBL1XR1 CDC42BPB CDC14B SNX29 DNAH1 SPTBN4 PARP10 ARHGAP6 CLMN LRRC1 NAXD LRP1 LRP5 LSS TTC17	7.18e-10	1489	338	42	28611215
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KNTC1 SPTBN2 PFAS CTIF SEMA4C FARP2 LRIG2 AARS2 KLHL14 FAM135A TRAPPC9 PDZRN4 PRUNE2 DMXL2 ATP13A1 CDC42BPB THOC5 ARHGEF15 MYOF DNAH17 HELZ2 CEP152	4.19e-09	493	338	22	15368895
Pubmed	Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2.	RELN LRP8 VLDLR LDLR LRP1	4.60e-09	8	338	5	10380922
Pubmed	Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death.	RYR1 RYR2 RYR3 ATP2A1 ATP2A3	4.60e-09	8	338	5	19033399
Pubmed	Reelin is a ligand for lipoprotein receptors.	RELN LRP8 VLDLR LDLR	8.76e-09	4	338	4	10571240
Pubmed	Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles.	RYR1 RYR2 RYR3 ATP2A1	8.76e-09	4	338	4	9384575
Pubmed	Reelin stabilizes the actin cytoskeleton of neuronal processes by inducing n-cofilin phosphorylation at serine3.	NES RELN SRC LRP8 VLDLR	1.03e-08	9	338	5	19129405
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	IGSF8 EMC1 GPAA1 ATR RPN2 LPCAT4 LAMC3 ZZEF1 LRP8 LRIG2 PTPRK TMEM131L DNAJC1 PLOD1 CREB3L2 MPG GALNT10 ITPRIPL2 PODXL RCN2 BRCC3 ATP9A UST LDLR LGALS3BP MYOF PLA2R1 LRP1 LRP5 CD70 TTC17 SCRIB ATP2A3 ATP6V0A2	3.12e-08	1201	338	34	35696571
Pubmed	PCSK9 binds to multiple receptors and can be functionally inhibited by an EGF-A peptide.	RELN LRP8 VLDLR LDLR	4.35e-08	5	338	4	18675252
Pubmed	Reelin receptors ApoER2 and VLDLR are expressed in distinct spatiotemporal patterns in developing mouse cerebral cortex.	NES RELN LRP8 VLDLR	1.29e-07	6	338	4	25308109
Pubmed	Localization of ApoER2, VLDLR and Dab1 in radial glia: groundwork for a new model of reelin action during cortical development.	NES RELN LRP8 VLDLR	1.29e-07	6	338	4	12586425
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH5 DNAH8 DNAH2 DNAH1 DNAH17	1.57e-07	14	338	5	9373155
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ACACB TMEM94 UNC5B SRC LRP8 SEMA4C FARP2 SBF1 FAM135A DSC3 DLGAP4 TRIOBP ECH1 YES1 ELMO2 LRRC1 SCRIB STX6	2.07e-07	421	338	18	36976175
Pubmed	Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development.	RELN SRC LRP8 YES1	3.00e-07	7	338	4	12526739
Pubmed	Isolation of several human axonemal dynein heavy chain genes: genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment.	DNAH5 DNAH8 DNAH2 DNAH1	3.00e-07	7	338	4	9256245
Pubmed	The PX-domain protein SNX17 interacts with members of the LDL receptor family and modulates endocytosis of the LDL receptor.	LRP8 VLDLR LDLR LRP1	3.00e-07	7	338	4	12169628
Pubmed	Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia.	DNAH5 DNAH8 DNAH2 DNAH17	3.00e-07	7	338	4	31178125
Pubmed	Reelin activates SRC family tyrosine kinases in neurons.	RELN SRC LRP8 VLDLR	5.95e-07	8	338	4	12526740
Pubmed	Sequential docking, molecular differentiation, and positioning of T-Tubule/SR junctions in developing mouse skeletal muscle.	RYR1 RYR2 RYR3 ATP2A1	5.95e-07	8	338	4	11784029
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	INTU DCDC1 USP11 VPS4A LPCAT4 KEAP1 BCOR ZZEF1 ANAPC10 CDC16 ZNF589 WWC1 VLDLR ACTR8 TUT4 OGT RNF31 PRSS56 HAUS5 ANGEL1 POLRMT RCN2 YTHDC2 INO80 TEP1 LDLR LGALS3BP PCSK6 LRP1 SCRIB	6.21e-07	1116	338	30	31753913
Pubmed	Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction.	LRP8 ANAPC10 VLDLR LDLR LRP1	6.50e-07	18	338	5	10827173
Pubmed	Reelin together with ApoER2 regulates interneuron migration in the olfactory bulb.	RELN LRP8 VLDLR	9.10e-07	3	338	3	23209795
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR1 RYR2 RYR3	9.10e-07	3	338	3	18403125
Pubmed	Abnormal positioning of granule cells alters afferent fiber distribution in the mouse fascia dentata: morphologic evidence from reeler, apolipoprotein E receptor 2-, and very low density lipoprotein receptor knockout mice.	RELN LRP8 VLDLR	9.10e-07	3	338	3	11920707
Pubmed	Differential functions of ApoER2 and very low density lipoprotein receptor in Reelin signaling depend on differential sorting of the receptors.	RELN LRP8 LDLR	9.10e-07	3	338	3	19948739
Pubmed	Binding of purified Reelin to ApoER2 and VLDLR mediates tyrosine phosphorylation of Disabled-1.	RELN LRP8 VLDLR	9.10e-07	3	338	3	12670700
Pubmed	Functional importance of covalent homodimer of reelin protein linked via its central region.	RELN LRP8 VLDLR	9.10e-07	3	338	3	21844191
Pubmed	Heterogeneous gene expression and functional activity of ryanodine receptors in resistance and conduit pulmonary as well as mesenteric artery smooth muscle cells.	RYR1 RYR2 RYR3	9.10e-07	3	338	3	18434746
Pubmed	The low density lipoprotein receptor prevents secretion of dense apoB100-containing lipoproteins from the liver.	VLDLR LDLR MTTP	9.10e-07	3	338	3	14583618
Pubmed	Reelin controls neuronal positioning by promoting cell-matrix adhesion via inside-out activation of integrin α5β1.	RELN LRP8 VLDLR	9.10e-07	3	338	3	23083738
Pubmed	SPRY domains in ryanodine receptors (Ca(2+)-release channels).	RYR1 RYR2 RYR3	9.10e-07	3	338	3	9204703
Pubmed	Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis.	RYR1 RYR2 RYR3	9.10e-07	3	338	3	21881589
Pubmed	Contributions of VLDLR and LRP8 in the establishment of retinogeniculate projections.	RELN LRP8 VLDLR	9.10e-07	3	338	3	23758727
Pubmed	ApoER2 function in the establishment and maintenance of retinal synaptic connectivity.	RELN LRP8 VLDLR	9.10e-07	3	338	3	21976526
Pubmed	Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors).	RYR1 RYR2 RYR3	9.10e-07	3	338	3	12213830
Pubmed	Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells.	RYR1 RYR2 RYR3	9.10e-07	3	338	3	25239916
Pubmed	Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).	RYR1 RYR2 RYR3	9.10e-07	3	338	3	11159936
Pubmed	Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization.	RYR1 RYR2 RYR3	9.10e-07	3	338	3	7959768
Pubmed	Regulation of mouse egg activation: presence of ryanodine receptors and effects of microinjected ryanodine and cyclic ADP ribose on uninseminated and inseminated eggs.	RYR1 RYR2 RYR3	9.10e-07	3	338	3	7635066
Pubmed	The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.	RYR1 RYR2 RYR3	9.10e-07	3	338	3	7876312
Pubmed	Functional consequences of hippocampal neuronal ectopia in the apolipoprotein E receptor-2 knockout mouse.	RELN LRP8 VLDLR	9.10e-07	3	338	3	18778775
Pubmed	The hepatic uptake of VLDL in lrp-ldlr-/-vldlr-/- mice is regulated by LPL activity and involves proteoglycans and SR-BI.	VLDLR LDLR LRP1	9.10e-07	3	338	3	18367731
Pubmed	Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.	RYR1 RYR2 RYR3	9.10e-07	3	338	3	22948152
Pubmed	Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain.	RYR1 RYR2 RYR3	9.10e-07	3	338	3	10788707
Pubmed	C-Terminal Region Truncation of RELN Disrupts an Interaction with VLDLR, Causing Abnormal Development of the Cerebral Cortex and Hippocampus.	RELN LRP8 VLDLR	9.10e-07	3	338	3	28123028
Pubmed	Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor.	RYR1 RYR2 RYR3	9.10e-07	3	338	3	7621815
Pubmed	Molecular identification of the ryanodine receptor pore-forming segment.	RYR1 RYR2 RYR3	9.10e-07	3	338	3	10473538
Pubmed	Reelin and its receptors, VLDLR and ApoER2, in melanocytic nevi.	RELN LRP8 VLDLR	9.10e-07	3	338	3	28255385
Pubmed	Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells.	RYR1 RYR2 RYR3	9.10e-07	3	338	3	9242641
Pubmed	A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice.	RYR1 RYR2 RYR3	9.10e-07	3	338	3	18643873
Pubmed	The organization of proteins in the human red blood cell membrane. A review.	RYR1 RYR2 RYR3	9.10e-07	3	338	3	4600883
Pubmed	FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane.	PDE3B EMC1 UNC5B SRC ATG2A SEMA4C LRIG2 TMEM131L DNAJC1 RNF31 DSC3 ATP13A1 RCN2 ZFPL1 CLMN PPP1R15B STX6 ATP6V0A2	9.58e-07	468	338	18	31056421
Pubmed	Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance.	LRP8 VLDLR LDLR LRP1	1.06e-06	9	338	4	20005821
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	EMC1 RPN2 USP11 PFAS LRIG2 PTPN4 PTPN6 TRMT10C SBF1 PTPRK PXN TMEM131L PLOD1 HSPA4 WWC1 EPM2A OGT POLRMT RCN2 YTHDC2 BRCC3 WDR97 LRRC1 LRP1 TTC17 GPSM1 ATP2A1	1.30e-06	974	338	27	28675297
Pubmed	MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm.	LRP8 VLDLR LDLR LRP1 LRP5	1.51e-06	21	338	5	21337463
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	RABEP2 EMC1 RPN2 SPTBN2 PFAS RB1CC1 BCOR FBXO38 PTPN4 PTPN6 TRMT10C SBF1 PTPRK PXN PLOD1 WASF1 CCDC22 DSC3 RCN2 TRIOBP BRCC3 TARS2 CDC42BPB CDC14B LRRC1 SCRIB CBX8 TTC33	1.71e-06	1049	338	28	27880917
Pubmed	Migration, early axonogenesis, and Reelin-dependent layer-forming behavior of early/posterior-born Purkinje cells in the developing mouse lateral cerebellum.	NES RELN LRP8 VLDLR	1.76e-06	10	338	4	20809939
Pubmed	Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach.	ABCA3 SPTBN2 SEMA4C DMXL2 TUT4 DYNC2I1 FREM3 ZNF446 IGHA1 ATP4A	2.18e-06	149	338	10	22664934
Pubmed	Functional dissection of Reelin signaling by site-directed disruption of Disabled-1 adaptor binding to apolipoprotein E receptor 2: distinct roles in development and synaptic plasticity.	RELN LRP8 VLDLR	3.61e-06	4	338	3	16481437
Pubmed	Disabled1 regulates the intracellular trafficking of reelin receptors.	RELN LRP8 VLDLR	3.61e-06	4	338	3	15718228
Pubmed	The central fragment of Reelin, generated by proteolytic processing in vivo, is critical to its function during cortical plate development.	RELN LRP8 VLDLR	3.61e-06	4	338	3	14724251
Pubmed	Structural basis for specific recognition of reelin by its receptors.	RELN LRP8 VLDLR	3.61e-06	4	338	3	20223215
Pubmed	Ryanodine receptor calcium release channels: lessons from structure-function studies.	RYR1 RYR2 RYR3	3.61e-06	4	338	3	23413940
Pubmed	Processing of Reelin by embryonic neurons is important for function in tissue but not in dissociated cultured neurons.	RELN LRP8 VLDLR	3.61e-06	4	338	3	17442808
Pubmed	Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum.	RYR1 RYR2 RYR3	3.61e-06	4	338	3	9607712
Pubmed	The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor.	VLDLR LDLR LRP1	3.61e-06	4	338	3	15863833
Pubmed	Expression and regulation of reelin and its receptors in the enteric nervous system.	RELN LRP8 VLDLR	3.61e-06	4	338	3	24844606
Pubmed	FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors.	LRP8 VLDLR LDLR	3.61e-06	4	338	3	22109552
Pubmed	Differential binding of ligands to the apolipoprotein E receptor 2.	RELN LRP8 VLDLR	3.61e-06	4	338	3	12899622
Pubmed	Conserved and divergent functions of Nfix in skeletal muscle development during vertebrate evolution.	RYR1 RYR2 RYR3	3.61e-06	4	338	3	23482488
Pubmed	A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.	RYR1 RYR2 RYR3	3.61e-06	4	338	3	18206662
Pubmed	Clusterin is a ligand for apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR) and signals via the Reelin-signaling pathway.	RELN LRP8 VLDLR	3.61e-06	4	338	3	24381170
Pubmed	Malformation of the radial glial scaffold in the dentate gyrus of reeler mice, scrambler mice, and ApoER2/VLDLR-deficient mice.	RELN LRP8 VLDLR	3.61e-06	4	338	3	12687696
Pubmed	Contribution of the Reelin signaling pathways to nociceptive processing.	RELN LRP8 VLDLR	3.61e-06	4	338	3	18279306
Pubmed	Structure of a receptor-binding fragment of reelin and mutational analysis reveal a recognition mechanism similar to endocytic receptors.	RELN LRP8 VLDLR	3.61e-06	4	338	3	17548821
Pubmed	Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation.	RELN LRP8 VLDLR	3.61e-06	4	338	3	10571241
Pubmed	Reelin receptors in developing laminated brain structures of mouse and human.	RELN LRP8 VLDLR	3.61e-06	4	338	3	15548227
Pubmed	Components of the reelin signaling pathway are expressed in the spinal cord.	RELN LRP8 VLDLR	3.61e-06	4	338	3	14750162
Pubmed	Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney.	SLC22A25 SLC22A6 SLC22A9	3.61e-06	4	338	3	15068970
Pubmed	LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo.	VLDLR LDLR LRP1	3.61e-06	4	338	3	15840700
Pubmed	Role for Reelin-induced cofilin phosphorylation in the assembly of sympathetic preganglionic neurons in the murine intermediolateral column.	RELN LRP8 VLDLR	3.61e-06	4	338	3	21039973
Pubmed	Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning.	RELN LRP8 VLDLR	3.61e-06	4	338	3	12167620
Pubmed	Reelin provides an inhibitory signal in the migration of gonadotropin-releasing hormone neurons.	RELN LRP8 VLDLR	3.61e-06	4	338	3	16207762
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	TMEM94 UNC5B SPTBN2 SRC LRP8 SEMA4C FARP2 ARHGAP31 PROM2 FAM135A DSC3 PODXL ABCC5 YES1 CDC42BPB PIEZO2 CRACDL SCRIB STX6	3.81e-06	569	338	19	30639242
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	DOCK4 ACACB SPTBN2 CTIF ATG2A CLIP1 BUB1B PXN DNMBP PLOD1 DYNC1I1 CCDC22 HAUS5 RCN2 DYNC2I1 CFI ECH1 YES1 ELMO2 AASS NINL TTC17 CEP152 CBX8	3.99e-06	853	338	24	28718761
Pubmed	TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.	EMC1 RPN2 LRIG2 PLOD1 DSC3 IDUA LDLR LGALS3BP TENM4 LRP1	5.15e-06	164	338	10	32409323
Pubmed	Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa.	SLC22A25 SLC22A6 SLC22A20P SLC22A9	5.85e-06	13	338	4	15369770
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	PDE3B EMC1 ATR RPN2 PFAS ZZEF1 FARP2 PSME4 SBF1 BUB1B EPN1 DMXL2 OGT RNF31 ANGEL1 POLRMT YTHDC2 TARS2 ELMO2 SCRIB	7.12e-06	650	338	20	38777146
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	FBXO40 INTU ZNF490 AARS2 ARHGAP31 ZNF644 INO80 MYOF	7.81e-06	103	338	8	10574462
Pubmed	Stage-specific association of apolipoprotein A-I and E in developing mouse retina.	LRP8 VLDLR LDLR LRP1	8.12e-06	14	338	4	17389516
Pubmed	Interaction of reelin signaling and Lis1 in brain development.	RELN LRP8 VLDLR	8.97e-06	5	338	3	14578885
Pubmed	Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells.	RYR1 RYR2 RYR3	8.97e-06	5	338	3	19011160
Pubmed	Mice with Dab1 or Vldlr insufficiency exhibit abnormal neonatal vocalization patterns.	RELN LRP8 VLDLR	8.97e-06	5	338	3	27184477
Pubmed	Impact of the Reelin signaling cascade (ligands-receptors-adaptor complex) on cognition in schizophrenia.	RELN LRP8 VLDLR	8.97e-06	5	338	3	22419519
Pubmed	Distinct roles of ATM and ATR in the regulation of ARP8 phosphorylation to prevent chromosome translocations.	ATR ACTR8 INO80	8.97e-06	5	338	3	29759113
Pubmed	Critical Role of SREBP-1c Large-VLDL Pathway in Environment-Induced Hypertriglyceridemia of Apo AV Deficiency.	VLDLR LDLR LRP1	8.97e-06	5	338	3	30700132
Pubmed	Normal sorting but defective endocytosis of the low density lipoprotein receptor in mice with autosomal recessive hypercholesterolemia.	VLDLR LDLR LRP1	8.97e-06	5	338	3	12746448
Pubmed	Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo.	VLDLR LDLR LRP1	8.97e-06	5	338	3	18992221
Cytoband	8q24.3	EPPK1 GPAA1 TRAPPC9 ZNF251 PARP10 WDR97 SCRIB	2.22e-05	113	339	7	8q24.3
GeneFamily	Low density lipoprotein receptors	LRP8 VLDLR LDLR LRP1 LRP5	3.54e-07	13	227	5	634
GeneFamily	Dyneins, axonemal	DNAH5 DNAH8 DNAH2 DNAH1 DNAH17	1.63e-06	17	227	5	536
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR2 RYR3	1.95e-06	3	227	3	287
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	FARP2 DNMBP ARHGEF6 FGD3 FGD2 ARHGEF15	1.78e-04	66	227	6	722
GeneFamily	Acyl-CoA synthetase family	ACSM4 ACSM2A ACSL5 ACSM2B	2.91e-04	26	227	4	40
GeneFamily	Fibronectin type III domain containing	TSPOAP1 LRFN3 PTPRK CNTN5 COL14A1 USH2A CNTFR CSF3R	9.50e-04	160	227	8	555
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	SPTBN2 FARP2 PRKD3 SBF1 ARHGEF6 FGD3 FGD2 TRIOBP SPTBN4	1.21e-03	206	227	9	682
GeneFamily	Gamma-aminobutyric acid type A receptor subunits	GABRB1 GABRB3 GABRD	1.63e-03	19	227	3	563
GeneFamily	WD repeat domain containing	DYNC1I1 DMXL2 WDR36 DYNC2I1 TEP1 TBL1XR1 WDR47 WDR97 WDR87 WDR73	1.81e-03	262	227	10	362
GeneFamily	EF-hand domain containing\|Spectrins	SPTBN2 SPTBN4	3.16e-03	7	227	2	1113
GeneFamily	MOB kinase activators\|STRIPAK complex	MOB2 MOB3A	3.16e-03	7	227	2	647
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	CDC16 TTC5 OGT TTC17 GPSM1 TTC33	3.31e-03	115	227	6	769
GeneFamily	NLR family	CIITA NLRP8 NLRP13	3.66e-03	25	227	3	666
GeneFamily	SPOUT methyltranferase domain containing	MRM1 TRMT10C	4.18e-03	8	227	2	1294
Coexpression	GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN	ABCA3 LRRC45 TSPOAP1 ZZEF1 EME2 DNMBP FGD3 RNF31 RCCD1 DLGAP4 ATG2B POLRMT TARS2 ZNF496 HELZ2	5.67e-08	200	338	15	M6208
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DOCK4 KDM3A ATR CTIF RB1CC1 ZZEF1 CLIP1 PTPN4 ANAPC10 UBE2G1 PSME4 PTPRK CDC16 BUB1B TMEM131L MTCL1 DNMBP WASF1 WWC1 CREB3L2 RAD51C DOCK1 VLDLR DMXL2 TUT4 OGT PODXL UST LDLR TGFBR3 MYOF PHF3	8.47e-08	856	338	32	M4500
Coexpression	GSE3982_EOSINOPHIL_VS_DC_UP	ACACB TSPOAP1 PCTP CNTN5 TMEM131L COL14A1 ARHGEF6 TUT4 DSC3 RGS14 PRF1 CES3	1.16e-05	199	338	12	M5399
Coexpression	GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN	RABEP2 KDM3A ATG2A HERC6 RNF31 DNAH2 XKR8 ZNF446 ZFPL1 LGALS3BP HELZ2 LRP2BP	1.22e-05	200	338	12	M7814
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	IGSF8 ABCA3 EMC1 GPAA1 RPN2 ZZEF1 SEMA4C PKD1 PLOD1 MPG OGT ATP13A1 ABCC5 ARMC9 LDLR SNX29 TENM4 LRP1	3.14e-05	457	338	18	M1613
Coexpression	GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_DN	SEMA4C CD163L1 PDZRN4 ITPRIPL2 NELFCD USHBP1 CLMN LPO TMEM26	3.43e-05	124	338	9	M8923
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	IGSF8 ABCA3 EMC1 GPAA1 RPN2 ZZEF1 SEMA4C PKD1 PLOD1 MPG OGT ATP13A1 ABCC5 ARMC9 LDLR SNX29 TENM4 LRP1	4.52e-05	470	338	18	MM1053
Coexpression	GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP	KDM3A BCOR RXRA FAM78A ZNF589 TRIM8 FGD3 ABCC5 MOB3A TBL1XR1 WDR73	5.18e-05	196	338	11	M3668
Coexpression	GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP	NES RELN RYR3 SARDH COL10A1 DYNC2I1 ARMC9 TEP1 TBL1XR1 AASS EGFL8	6.21e-05	200	338	11	M7777
Coexpression	GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP	PDE6B UNC5B THAP3 USH2A OGT ECM2 DLGAP4 ABCC5 TEP1 DNAH17 LPO	6.21e-05	200	338	11	M5192
Coexpression	GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN	ABCA3 PTPN6 CIITA PIK3CD DNAH8 CREB3L2 GALNT12 SNX29 LGALS3BP ARHGAP6 TMEM26	6.21e-05	200	338	11	M7833
Coexpression	BROWNE_HCMV_INFECTION_48HR_DN	ACACB FARP2 PRKD3 NCR1 HSPA4 MPG PRUNE2 CCDC22 ECM2 DLGAP4 ANGEL1 IDUA TEP1 CDC14B SNX29 ZFPL1 LGALS3BP ARHGAP6	6.24e-05	482	338	18	M12144
Coexpression	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	PDE3B EMC1 PFAS PCTP FBXL18 DNMBP WASF1 ATG2B IRGQ CFI RGS14 AASS	6.47e-05	237	338	12	M7068
Coexpression	SMID_BREAST_CANCER_NORMAL_LIKE_UP	RELN ACACB HLA-DOB LPCAT4 LAMC3 CIITA PIK3CD COL14A1 ANGEL1 CFI TEP1 TGFBR3 CD1D CD22 IGHA1 AASS PRF1 ATP2A3	6.75e-05	485	338	18	M8513
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_DN	IGSF8 EPPK1 EMC1 CTIF ZZEF1 SEMA4C MGAT2 SBF1 PTPRK DNAJC1 CREB3L2 OGT ATP13A1 POLRMT ABCC5 ARMC9 LDLR TGFBR3 PPP1R15B HELZ2 LRP1 ATP6V0A2	8.48e-05	681	338	22	M5314
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GABRB1 GABRB3 ACACB PTPN4 MTCL1 CREB3L2 GALNT10 ARHGAP6 TENM4 CLMN NINL	2.54e-07	191	338	11	963f4f2e852bbb4faf070aafb0d368297abacd3b
ToppCell	human_hepatoblastoma-Tumor_cells-T8\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ACACB SARDH ABCC6 SLC22A9 CSF3R AASS PCSK6 LSS ACSM2A ACSL5 ACSM2B	2.67e-07	192	338	11	e785135262f4c9cc66c403bf362bb34643b212c5
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 NES UNC5B ARHGAP31 NPTX2 PODXL ARHGEF15 TGFBR3 PIEZO2 USHBP1 TMEM26	3.29e-07	196	338	11	d323f7dc41380446e5967c69832bea88351a9331
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INTU PDE3B FAM178B CTIF CIITA DNMBP WASF1 PRUNE2 TEP1 RGS14	6.25e-07	167	338	10	f5bffa77061baec0ba87bd688a047595f32534db
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ACRBP HLA-DOB RYR1 CIITA CFI UST CD1D TENM4 AASS CES3	6.60e-07	168	338	10	d60f7cd8269f373827f49c7785002cb38e4570a9
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ACRBP HLA-DOB RYR1 CIITA CFI UST CD1D TENM4 AASS CES3	6.97e-07	169	338	10	ccd98f9005aa0a88bd49f153be4e7200cc3dd0ac
ToppCell	droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES UNC5B DDN FBXL18 CNTN5 TCAF2 SLC5A5 PLA2R1 PIEZO2 EFCC1	6.97e-07	169	338	10	87116c33c5ca8cb1862e103e5607b1df4d264569
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_naive\|bone_marrow / Manually curated celltypes from each tissue	HLA-DOB RYR1 PTPRK CIITA TRPV3 KAZALD1 WASF1 CDC42BPB SNX29 CD22	7.76e-07	171	338	10	fcc31a9a69f96de10d1324a5a4fbfe4289bf4984
ToppCell	Endothelial-B-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	RELN KLHL14 WASF1 DYNC1I1 PODXL TGFBR3 PIEZO2 PCSK6 EFCC1 ACSM2B	8.63e-07	173	338	10	a81992965137195d20fc498f750975303961a828
ToppCell	Control-B_cells-B_cells\|Control / group, cell type (main and fine annotations)	RABEP2 CIITA PIK3CD TMEM131L KLHL14 CLNK DNAH8 SNX29 CD22 ATP2A3	1.01e-06	176	338	10	d2c353783bd78dc24f28e00d917b88d8294fb5df
ToppCell	3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho\|lymph-node_spleen / Manually curated celltypes from each tissue	RYR3 PCTP LRP8 FBXL18 DNAH8 PODXL MYOF LRP1 LSS CBX8	1.06e-06	177	338	10	53040dbeb18574a48e352e4bce252c7c3018762c
ToppCell	droplet-Heart-4Chambers-21m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN LPCAT4 RYR3 PTPN4 CD163L1 ARMC9 LRRC46 LRRC1 EFCC1 TMEM26	1.59e-06	185	338	10	bb5a4cf93534b9bcd0923f314c389d571e91e7f8
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GABRB3 ACACB SLC22A6 FAM151A WWC1 PRUNE2 ABCC6 SNX29 ACSM2A ACSM2B	1.75e-06	187	338	10	3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	ABCA3 EPPK1 GART DNAH5 WWC1 ARMC9 INO80 CSF3R AASS PCSK6	1.84e-06	188	338	10	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	facs-Thymus-Epithelium-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACRBP SPTBN2 SLC6A19 ANAPC10 PXN DNMBP ACTR8 ZNF7	1.97e-06	110	338	8	3a641dced828ed97a8eea70d0a7b76f33630c9be
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	FARP2 PRKD3 CIITA VLDLR RCN2 MOB3A SNX29 WDR97 CD22 PPP1R15B	2.32e-06	193	338	10	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	NS-moderate-d_07-13-Epithelial-Secretory\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LPCAT4 PTPRK PROM2 HERC6 PODXL GALNT12 ERN2 LGALS3BP MYOF PLA2R1	2.67e-06	196	338	10	47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 RIN3 RYR1 CIITA ARHGAP31 FMN1 CD163L1 FGD2 CSF3R LRP1	2.79e-06	197	338	10	8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5
ToppCell	Adult-Immune-dendritic_cell-D122\|Adult / Lineage, Cell type, age group and donor	KNTC1 HLA-DOB MGAT2 CIITA EME2 CLNK ZDHHC12 LAS1L ATP2A3	2.79e-06	154	338	9	64a4686586d08b1e9632dde917b472ac660de2d3
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	RB1CC1 CLIP1 LRRIQ1 TRIM8 DNAH5 DYNC2I1 YES1 TBL1XR1 TOB1 PHF3	3.05e-06	199	338	10	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NES PDE3B PXN TCAF2 PODXL DLGAP4 ARHGEF15 TGFBR3 ARHGAP6 TMEM26	3.05e-06	199	338	10	dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53
ToppCell	10x5'-Liver-Myeloid_Mac-Intestinal_macrophages\|Liver / Manually curated celltypes from each tissue	INTU UNC5B CD163L1 NYNRIN PRUNE2 ABCC5 PIEZO2 USHBP1 TMEM26	3.10e-06	156	338	9	9a897fc79c4fae94c5f2e9012d65297f9225e5e3
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RABEP2 FAM78A HAUS5 XKR8 IDUA CFI PPP1R15B MTTP ATP6V0A2	3.45e-06	158	338	9	1d78578dc1f8ba43dacdccae1082c0b9d749f64d
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6\|TCGA-Stomach / Sample_Type by Project: Shred V9	ATR LPCAT4 LRP8 DNMBP IQCE ATP13A1 LDLR CLMN LRRC1	3.63e-06	159	338	9	655c0749c238bd68cb797adb83e25a23b8a3cc9d
ToppCell	Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ACRBP PTPN6 MGAT2 FGD3 FGD2 TEP1 THUMPD2 PARP10 CSF3R	5.16e-06	166	338	9	063d68f2ffb40770cb4601fa1cb6426ae26f7a37
ToppCell	Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Junb_(Microglia)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ACRBP PTPN6 MGAT2 FGD3 FGD2 TEP1 THUMPD2 PARP10 CSF3R	5.16e-06	166	338	9	f28d07715e6b00ca2a0df39273c5f569744be5a8
ToppCell	Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Junb_(Microglia)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ACRBP PTPN6 MGAT2 FGD3 FGD2 TEP1 THUMPD2 PARP10 CSF3R	5.16e-06	166	338	9	417cfb207da08fa1a0fd5f2a13c8786628667a8e
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-NK_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RIPK2 UNC13D MOB2 PIK3CD NCR1 MIEF2 RGS14 PRF1 CRACDL	5.97e-06	169	338	9	a24d12199b1a6d9cb243b3a68f4109d3a30b2dcb
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-CD45____NK_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RIPK2 UNC13D MOB2 PIK3CD NCR1 MIEF2 RGS14 PRF1 CRACDL	5.97e-06	169	338	9	573f85075d83a4baba41c3e24dc4d9831823a5e5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RIN3 UNC5B FAM178B LINC00528 RYR1 AARS2 IRGQ RGS14 CSF3R	6.26e-06	170	338	9	be2a34c70665d8d11332b1a70eda03d77cb7f7dd
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac\|metastatic_Lymph_Node / Location, Cell class and cell subclass	KNTC1 RXRA EME2 DNHD1 OGT ABCC5 DNAH1 LPO EFCC1	6.88e-06	172	338	9	f673a2e697b46e7cfa4186cb3fb2b98e3c83703e
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	LRRC45 HLA-DOB ZNF490 CLNK NAALADL1 HAUS5 ATG2B ERN2 FAM72B	6.88e-06	172	338	9	1215f61f115b042f84721b64c2ed1f48081535f1
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KNTC1 TSPOAP1 PTPN4 DNAH8 PDZRN4 ERN2 CDC14B TMEM87B TMEM26	7.21e-06	173	338	9	8bffd512a4e561e23cc04478e2ca6fd5d3771fe4
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KNTC1 TSPOAP1 PTPN4 DNAH8 PDZRN4 ERN2 CDC14B TMEM87B TMEM26	7.21e-06	173	338	9	3e3c61468e703330788a10d850ef41a85680f86d
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RABEP2 HLA-DOB TMEM131L KLHL14 CLNK SNX29 CD22 CD70 ATP2A3	1.04e-05	181	338	9	8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A19 BCOR RYR2 CNTN5 USH2A WNT9B ABCC6 SNX29 ACSM2A	1.04e-05	181	338	9	c80ffa2ded5975a88e9a1a7d333196f95237bf0a
ToppCell	droplet-Lung-nan-3m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RXRA KAZALD1 PRUNE2 DMXL2 ITPRIPL2 ABCC5 MYOF CLMN CES3	1.13e-05	183	338	9	ec3c05b9ce1e0fbb720e0dea41f1e28fd3fd878f
ToppCell	facs-Liver-Hepatocytes-24m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FARP2 SARDH WWC1 ATP9A LDLR ABCC6 IGFALS CES3 MTTP	1.13e-05	183	338	9	d0721c6aa426953a520d40e976b6e65aa7ca65e8
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SSPOP RYR2 RYR3 USH2A DNAH5 DNAH1 PIEZO2 TENM4	1.18e-05	184	338	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	nucseq-Immune-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	HLA-DOB TMEM131L KLHL14 CREB3L2 SNX29 CD22 IGHA1 CD70 ATP2A3	1.18e-05	184	338	9	911658e7bb499c1bbc8419eec8ff88729bc39a75
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GABRB1 ACACB LRP5L CREB3L2 GALNT10 SPTBN4 ARHGAP6 TENM4 NINL	1.18e-05	184	338	9	e8238fe58f94b4f5700ab7f343fb06ea61e899a9
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SSPOP RYR2 RYR3 USH2A DNAH5 DNAH1 PIEZO2 TENM4	1.18e-05	184	338	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SSPOP RYR2 RYR3 USH2A DNAH5 DNAH1 PIEZO2 TENM4	1.18e-05	184	338	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	HLA-DOB TMEM131L KLHL14 CREB3L2 SNX29 CD22 IGHA1 CD70 ATP2A3	1.18e-05	184	338	9	942b58ae7172bb5f97e55b032db9329d161854af
ToppCell	droplet-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN UNC5B KAZALD1 COMP PCSK6 LRRC1 MTTP EFCC1 TMEM26	1.24e-05	185	338	9	6a85399cfdb9b89683c874e7f046957f9a601dc2
ToppCell	droplet-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN UNC5B KAZALD1 COMP PCSK6 LRRC1 MTTP EFCC1 TMEM26	1.24e-05	185	338	9	64791056cdbb739136dbef08f4b16e2b5427faad
ToppCell	COVID-19-lung-B_cells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PIK3CD TMEM131L KLHL14 FGD2 UST CD22 IGHA1 CD70 ATP2A3	1.24e-05	185	338	9	e8f1ad580f19705b5ca1d7d8867b2125f4891684
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRM1 RXRA FAM78A MTCL1 DNAH8 FAM135A CCDC22 RNF31 USHBP1	1.29e-05	186	338	9	02418c50fdcca549bf73dedf6199ab4a27862a9b
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRM1 RXRA FAM78A MTCL1 DNAH8 FAM135A CCDC22 RNF31 USHBP1	1.29e-05	186	338	9	39e475a3c167b33daa63b0c1bfa32451c5f46635
ToppCell	IPF-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	HLA-DOB FARP2 KLHL14 DNMBP FGD2 UST SNX29 CD22 IGHA1	1.35e-05	187	338	9	af1327559f7e01bec070881cae52834917c3da65
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC22A6 WWC1 PRUNE2 ABCC6 SNX29 ARHGAP6 NINL ACSM2A ACSM2B	1.59e-05	191	338	9	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC22A6 WWC1 PRUNE2 ABCC6 SNX29 ARHGAP6 NINL ACSM2A ACSM2B	1.59e-05	191	338	9	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK4 PDE3B ARHGAP31 FAM135A PODXL ANGEL1 YES1 ARHGEF15 PIEZO2	1.73e-05	193	338	9	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FARP2 PRKD3 TMEM131L UFC1 RCN2 MOB3A SNX29 CD22 ATP2A3	1.80e-05	194	338	9	d852aebf7a763b9a776c4570711f0c759f591910
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRK FAM135A WWC1 PRUNE2 SNX29 ARHGAP6 NINL ACSM2A ACSM2B	1.80e-05	194	338	9	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RABEP2 HLA-DOB CIITA KLHL14 CLNK DNAH8 FGD2 CD22 ACSM2A	1.88e-05	195	338	9	3311a1bf4ed94820b45047d44fc14b14ac72e6fb
ToppCell	NS-moderate-d_16-33-Epithelial-Secretory\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LPCAT4 PTPRK PROM2 PODXL GALNT12 ERN2 LGALS3BP MYOF PLA2R1	1.96e-05	196	338	9	70384c1da9baed843f414cfd1403ddd586a2db07
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK4 PDE3B ARHGAP31 DNAJC1 TCAF2 PODXL ARHGEF15 TGFBR3 TMEM26	1.96e-05	196	338	9	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Trm_Tgd\|GI_small-bowel / Manually curated celltypes from each tissue	RIN3 PTPN4 NCR1 CLNK MPG NAALADL1 MOB3A YES1 PRF1	1.96e-05	196	338	9	84cab9390794fe50203834b745722bf11c208ebd
ToppCell	Fetal_29-31_weeks-Immune-monocyte-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RIN3 CIITA PIK3CD FMN1 FGD3 DMXL2 FGD2 CD1D CSF3R	2.04e-05	197	338	9	8b9a88fb671d5c2b25d291c851e2b8a478f2610c
ToppCell	Biopsy_Other_PF-Immune-Mast_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	CLNK ARHGEF6 SNX29 SLC22A9 ARHGAP6 CD22 ATP2A3 HCRTR1 ATP6V0A2	2.12e-05	198	338	9	9f015553598d4c6774b2f9759e8c0f0f93e51c67
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RELN SSPOP CD163L1 KLHL14 WNT9B PIEZO2 USHBP1 ACSM2A ACSM2B	2.12e-05	198	338	9	306e28d31fd587409a12dcccc6b2abd7dc9c2e0a
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RELN SSPOP CD163L1 KLHL14 WNT9B PIEZO2 USHBP1 ACSM2A ACSM2B	2.12e-05	198	338	9	05429f18e1d74880c1835568c86177f661b3477a
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC6A19 MEP1A FAM151A NAALADL1 LGALS3BP TREH UGT2A3 MTTP ACSL5	2.12e-05	198	338	9	2967fb2d94662997bfe932ac299c80d6f182fb48
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC6A19 MEP1A FAM151A NAALADL1 LGALS3BP TREH UGT2A3 MTTP ACSL5	2.12e-05	198	338	9	222a060c2c63d30da34e4b71c37aa27a048d7d09
ToppCell	COVID-19-lung\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK4 PDE3B ABCA3 CIITA FMN1 DMXL2 FGD2 CSF3R LRP1	2.21e-05	199	338	9	155b03b859157013e9142e9248551369127d9204
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	LAMC3 FAM78A CREB3L2 ARMC9 ARHGAP6 PLA2R1 CD1D CD22 ACSL5	2.30e-05	200	338	9	25f4c051c2e869481f33c22ad54de97efac444ad
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	LAMC3 FAM78A CREB3L2 ARMC9 ARHGAP6 PLA2R1 CD1D CD22 ACSL5	2.30e-05	200	338	9	da45a85a4667965b24ba824af871157af5b4cd19
ToppCell	facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KNTC1 KLHL14 DNAH8 RAD51C ZNF251 CD22 PRF1 CEP152	2.70e-05	157	338	8	0fecc14959c4c9efc19d5c06475a890e0a30f148
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GABRD HLA-DOB PRUNE2 FGD2 ARMC9 ZNF446 CD22 WDR87	2.70e-05	157	338	8	29622bac6b16bb39cec4319bf4c4f92d33345e8a
ToppCell	TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue\|TCGA-Thryoid / Sample_Type by Project: Shred V9	RELN IGFBPL1 RYR2 LRRIQ1 CNTN5 SLC5A5 PLA2R1 CLMN	2.83e-05	158	338	8	8e48952af0831a1fc71ad422e8216b5a92a75991
ToppCell	BAL-Severe-cDC_4\|Severe / Compartment, Disease Groups and Clusters	ACACB UNC13D KAZALD1 CFI UST TENM4 AASS CES3	2.83e-05	158	338	8	73f66689ef59f71b14cb7141ca5951cc47fe57c1
ToppCell	TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue\|TCGA-Thryoid / Sample_Type by Project: Shred V9	RELN IGFBPL1 RYR2 LRRIQ1 CNTN5 SLC5A5 PLA2R1 CLMN	2.83e-05	158	338	8	e5b55c15a8c99c8d7fc94949f0d3c22e0c3fee7b
ToppCell	TCGA-Thryoid-Solid_Tissue_Normal\|TCGA-Thryoid / Sample_Type by Project: Shred V9	RELN IGFBPL1 RYR2 LRRIQ1 CNTN5 SLC5A5 PLA2R1 CLMN	2.83e-05	158	338	8	55214d674808584e4d48f8c5e3b8c0e206cb9bb8
ToppCell	Thalamus\|World / BrainAtlas - Mouse McCarroll V32	FBXO40 UMODL1 WNT9B POU4F1 FREM3 CLMN ATP2A1	2.94e-05	116	338	7	5ddfb2dd5459ff6d7ae38163a38eae64fda283b7
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	RELN TMEM132B RYR1 RYR2 CNTN5 USH2A DNAH8 PDZRN4	2.96e-05	159	338	8	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3B HLA-DOB POLRMT TENM4 CD22 MTTP WDR73 LSS	2.96e-05	159	338	8	74655c22e9fdd88e3052b9dfb954c8fb678bd2d8
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	LINC00528 RYR2 RYR3 COL14A1 PDZRN4 PRUNE2 ECM2 DACT3	3.24e-05	161	338	8	64891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCell	Substantia_nigra-Neuronal-Excitatory\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	GABRD DDN WNT9B FREM3 RGS14 GPR150 GAST	3.28e-05	118	338	7	9f1d744f46d79ff2ab7f168f54fdbd9f4640dddd
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1\|E16.5-samps / Age Group, Lineage, Cell class and subclass	DOCK4 RIN3 RYR3 COL14A1 CASS4 VLDLR ZNF7 LRP1	3.54e-05	163	338	8	f1ec2625b52664308968b01d8e0275e1e0751480
ToppCell	Bronchial_Biopsy-Endothelial-Lymphatic\|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X	GABRB3 RELN UNC5B SSPOP VLDLR PIEZO2 PCSK6 ACSM2A	3.54e-05	163	338	8	961c3a1303108afd680365466045f3460a30a7b0
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	FARP2 CIITA RCN2 MOB3A SNX29 CD22 IGHA1 PPP1R15B	3.54e-05	163	338	8	6bed27d2f67a430a847da5eb47878d14b4949c45
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RELN KLHL14 CREB3L2 GALNT10 PRSS56 SLC5A5 PCSK6	3.85e-05	121	338	7	056d0f0f7a4d1b2d38b83647bbe4468b7c959ce6
ToppCell	356C-Fibroblasts-Fibroblast-D\|356C / Donor, Lineage, Cell class and subclass (all cells)	RELN RYR2 CNTFR ARHGEF15 PLA2R1 PIEZO2 PCSK6 EFCC1	4.02e-05	166	338	8	7286a37b2827f3747469ffd0d76cbe81116db7ee
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RIN3 LINC00528 CIITA ARHGAP31 CLNK ARHGEF6 EEF1AKMT4-ECE2 FGD2	4.02e-05	166	338	8	63dc58864268b4e7779e4c45155022556fc634f9
ToppCell	356C-Fibroblasts-Fibroblast-D-\|356C / Donor, Lineage, Cell class and subclass (all cells)	RELN RYR2 CNTFR ARHGEF15 PLA2R1 PIEZO2 PCSK6 EFCC1	4.02e-05	166	338	8	7c2eee0a4f45795a956acf936b85bdb35f1b1624
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Sc17a7.Fermt1_(Subiculum/Parasubiculum)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CHRNE NAALADL1 COL10A1 DSC3 FREM3	4.11e-05	51	338	5	f71a194642de9ce603390c5063ea62d755efd1a8
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Sc17a7.Fermt1_(Subiculum/Parasubiculum)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CHRNE NAALADL1 COL10A1 DSC3 FREM3	4.11e-05	51	338	5	be47f4d9c720b8e3a5698227a2dc7629e1dc61b7
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	GABRB1 DOCK4 DDN INKA2 RYR3 WASF1 RGS14 CRACDL	4.38e-05	168	338	8	6db453cbbbaf4144a86fadcfa5805d33396713b5
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NES DDN RYR3 DYNC1I1 PODXL TGFBR3 PLA2R1 GPSM1	4.38e-05	168	338	8	fc80e4fecfc92458eb627013a983041d8ca025a9
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	BUB1B PXN SARDH ACTR8 TGFBR3 TOB1 PRF1 ATP2A3	4.38e-05	168	338	8	50991eb794742592a0c96cd9a72460ab339e74ff
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NES DDN RYR3 DYNC1I1 PODXL TGFBR3 PLA2R1 GPSM1	4.38e-05	168	338	8	315ca578c945aeeb77acda2727f3e6db8b43f43e
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLA-DOB SSPOP RYR1 CIITA FGD2 RCCD1 SPTBN4 MTTP	4.57e-05	169	338	8	46f0f0de9a0894c454f93032e7a7a800f47c8276
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac\|Myeloid_cells / Location, Cell class and cell subclass	KNTC1 DNHD1 OGT ABCC5 ERN2 DNAH1 LPO EFCC1	4.57e-05	169	338	8	dba8f5599aa21feef5b7fdfed2e3ab54748d80f7
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DCDC1 CTIF DNAH5 NPTX2 CFAP73 CRACDL SCRIB EGFL8	4.97e-05	171	338	8	1854a777d9eb9d3fc3ed3632332a6f89ce8131da
ToppCell	COVID-19-kidney-Bcells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PIK3CD TMEM131L KLHL14 UST CD22 IGHA1 CD70 ATP2A3	4.97e-05	171	338	8	8e8fb79968b1a5c34d1d9cad7f9155fabfdb7cc7
ToppCell	356C-Lymphocytic-ILC-ILC-2\|ILC / Donor, Lineage, Cell class and subclass (all cells)	BTBD6 TRAPPC9 CCDC22 ATG2B IDUA DNAH17 CD70 ACSM2B	5.17e-05	172	338	8	4977e1f4deae781750e27a8054deccd336cfb74a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NES DDN RYR3 DYNC1I1 PODXL TGFBR3 PLA2R1 GPSM1	5.17e-05	172	338	8	6c17a1e586a72d1bd80c20c06370429c61dc9f85
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK4 RYR1 FGD2 TEP1 UST CDC42BPB DNAJC17 DACT3	5.17e-05	172	338	8	2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NES DDN RYR3 DYNC1I1 PODXL TGFBR3 PLA2R1 GPSM1	5.17e-05	172	338	8	381ae1c3c07d0a424f43455ec571653b192a946a
Drug	R 478	RYR1 RYR2 RYR3 HSPA4 ATP2A3	2.88e-07	11	335	5	CID000084223
Drug	MBED	RYR1 RYR2 RYR3 HSPA4	6.75e-07	6	335	4	CID000129958
Drug	cis-diammineplatinum(II	RYR1 RYR2 RYR3	3.16e-06	3	335	3	CID000159790
Drug	2-hydroxyheptanoic acid	RYR1 RYR2 RYR3	3.16e-06	3	335	3	CID002750949
Drug	8N3-cADPR	RYR1 RYR2 RYR3	3.16e-06	3	335	3	CID000127713
Drug	aminodantrolene	RYR1 RYR2 RYR3	3.16e-06	3	335	3	CID009570289
Drug	2-hydroxycarbazole	RYR1 RYR2 RYR3	3.16e-06	3	335	3	CID000093551
Drug	Ryanodyl 3-(pyridine-3-carboxylate	RYR1 RYR2 RYR3	3.16e-06	3	335	3	CID005748312
Drug	sevoflurane	GABRB1 GABRB3 GABRD DDN ZZEF1 RYR1 RYR3 PRKD3 TRAPPC9 LRP5	3.48e-06	105	335	10	CID000005206
Drug	Dirithromycin [62013-04-1]; Down 200; 4.8uM; HL60; HG-U133A	RABEP2 RIN3 EMC1 LPCAT4 KEAP1 PCTP ANGEL1 IRGQ TARS2 LDLR ELMO2 ATP2A3 ATP6V0A2	6.48e-06	194	335	13	1712_DN
Drug	AC1L380G	RYR1 RYR2 RYR3 ATP2A1 ATP2A3	6.57e-06	19	335	5	CID000084698
Drug	Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; MCF7; HT_HG-U133A	RELN ACACB TSPOAP1 RYR2 PRKD3 SBF1 FAM135A PDZRN4 NPTX2 SPTBN4 RGS14 DNAH17 ATP2A1	7.66e-06	197	335	13	2305_UP
Drug	Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; HL60; HT_HG-U133A	CTIF RYR2 PTPN4 MGAT2 IQCE DMXL2 TUT4 DLGAP4 ARMC9 THOC5 MYOF IGFALS DNAH17	7.66e-06	197	335	13	2532_DN
Drug	Furosemide [54-31-9]; Up 200; 12uM; MCF7; HT_HG-U133A	TSPOAP1 RYR1 RYR2 DYNC1I1 TUT4 OGT ECM2 CFI LCT CDC14B SLC5A5 MYOF CD70	8.09e-06	198	335	13	3197_UP
Drug	haloperidol; Up 200; 10uM; HL60; HT_HG-U133A	FBXO40 DCHS2 PDE6B FBXL18 COL14A1 PRUNE2 COL10A1 FGD2 IGFALS PHF3 AASS LSS TMEM140	9.01e-06	200	335	13	2704_UP
Drug	PCB74	RYR1 RYR2 RYR3	1.25e-05	4	335	3	CID000036218
Drug	148504-47-6	RYR1 RYR2 RYR3	1.25e-05	4	335	3	CID006444275
Drug	SC 38249	RYR1 RYR2 RYR3	1.25e-05	4	335	3	CID000134834
Drug	AC1L1U7A	RYR1 RYR2 RYR3	1.25e-05	4	335	3	CID000035682
Drug	Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A	LRFN3 IMPACT CLIP1 LRIG2 PXN ACTR8 CCDC22 TRIOBP ARMC9 CDC14B ATP2A3 CBX8	2.94e-05	192	335	12	7427_DN
Drug	Glutarates	SLC22A6 SLC22A20P SLC22A9	3.09e-05	5	335	3	ctd:D005977
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; HL60; HT_HG-U133A	PDE3B UNC5B ZNF589 WWC1 ACTR8 CCDC22 RNF31 HAUS5 NPEPL1 ELMO2 PHF3 STX6	3.09e-05	193	335	12	2366_DN
Drug	Tropicamide [1508-75-4]; Down 200; 14uM; MCF7; HT_HG-U133A	ACACB SRC INKA2 RYR2 MGAT2 ZNF589 PXN DLGAP4 IDUA TGFBR3 LSS ATP2A3	3.25e-05	194	335	12	3619_DN
Drug	Conessine [546-06-5]; Down 200; 11.2uM; MCF7; HT_HG-U133A	EPPK1 LPCAT4 ZZEF1 PRKD3 PIK3CD DMXL2 TUT4 DLGAP4 DYNC2I1 NPEPL1 SLC5A5 PCSK6	3.25e-05	194	335	12	2792_DN
Drug	Zalcitabine [7481-89-2]; Up 200; 19uM; HL60; HT_HG-U133A	ACACB SEMA4C ANGEL2 MTCL1 NPTX2 HAUS5 DYNC2I1 ERN2 CDC14B MYOF LRP5 ATP2A3	3.42e-05	195	335	12	2932_UP
Drug	Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A	RABEP2 DCHS2 SRC CTIF ZZEF1 FBXL18 HERC6 DOCK1 ERN2 PCSK6 LSS TTC33	3.59e-05	196	335	12	7025_UP
Drug	Propafenone hydrochloride [34183-22-7]; Down 200; 10.6uM; MCF7; HT_HG-U133A	NES PDE3B THAP3 ARHGEF6 IQCE RNF31 ARMC9 TEP1 ERN2 ZNF446 SLC5A5 ATP2A3	3.78e-05	197	335	12	5437_DN
Drug	Hecogenin [467-55-0]; Down 200; 9.2uM; HL60; HT_HG-U133A	RIN3 PDE6B DDN CASS4 GALNT10 UST THOC5 SLC5A5 PRF1 CD70 LSS ATP2A3	3.78e-05	197	335	12	2716_DN
Drug	Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A	EMC1 TMEM94 UNC5B LRFN3 SRC ZNF589 WWC1 EPM2A YTHDC2 ZFPL1 MYOF CEP152	3.78e-05	197	335	12	6773_DN
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A	RABEP2 RELN ACACB PDE6B RYR2 PIK3CD NYNRIN ANGEL2 NPTX2 ERN2 RGS14 MYOF	3.78e-05	197	335	12	3639_DN
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A	EMC1 LRFN3 SRC LPCAT4 PRKD3 SBF1 IRGQ ERN2 NPEPL1 UST CDC14B PCSK6	3.78e-05	197	335	12	1640_DN
Drug	Dextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A	EMC1 SRC LPCAT4 PXN GALNT10 ACTR8 RNF31 UST CLMN PCSK6 PCIF1 ATP2A3	3.78e-05	197	335	12	2636_DN
Drug	Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A	RABEP2 RIN3 EMC1 ACACB INKA2 THAP3 EPN1 DLGAP4 ERN2 SLC5A5 PCSK6 ATP2A3	3.97e-05	198	335	12	3621_DN
Drug	Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; PC3; HT_HG-U133A	RABEP2 KAZALD1 HERC6 EPN1 EPM2A IDUA ERN2 MYOF AASS PCSK6 DNAH17 CEP152	3.97e-05	198	335	12	5102_UP
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A	MRM1 ANGEL2 PXN HERC6 VLDLR EPM2A RNF31 GALNT12 TEP1 MYOF CES3 CEP152	3.97e-05	198	335	12	5242_DN
Drug	Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A	RABEP2 RELN EMC1 ACACB PDE6B RYR2 ZNF589 DLGAP4 ERN2 SLC5A5 PRF1 PCSK6	3.97e-05	198	335	12	3609_DN
Drug	Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; HL60; HG-U133A	RIN3 ACACB PRPF6 ATG2A CIITA OGT NPEPL1 SLC5A5 ELMO2 PCIF1 GAST PCBD1	4.17e-05	199	335	12	1375_UP
Drug	Methylatropine nitrate [52-88-0]; Down 200; 11uM; MCF7; HT_HG-U133A	PDE6B SEMA4C PRKD3 PXN HERC6 EPM2A RNF31 DSC3 HAUS5 ZFPL1 PHF3 LRP5	4.17e-05	199	335	12	6495_DN
Drug	vanadyl	PDE3B PDE6B SRC PRKD3 PTPN6 PTPRK PIK3CD NCR1 DNAH5 DNAH8 DNAH1 CD22 DNAH17 ATP2A1 ATP2A3	5.51e-05	307	335	15	CID000061671
Drug	Bicuculline	GABRB1 GABRB3 RYR1 RYR2 HCRTR1	5.95e-05	29	335	5	ctd:D001640
Drug	chloro-m-cresol	RYR1 RYR2 RYR3	6.11e-05	6	335	3	CID000012008
Drug	AC1O528X	RYR1 RYR2 RYR3	6.11e-05	6	335	3	CID006475857
Drug	NSC114784	RYR1 RYR2 RYR3	6.11e-05	6	335	3	CID000419425
Drug	strontium	KNTC1 RYR1 RYR2 RYR3 PRKD3 ATP2A1 ATP2A3	6.30e-05	68	335	7	CID000104798
Drug	Rescinnamin [24815-24-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A	EMC1 PIK3CD ZNF589 TRAPPC9 DLGAP4 ERN2 LDLR MYOF CD22 PRF1 LSS	8.09e-05	181	335	11	2785_UP
Drug	[[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate	RYR1 RYR2 RYR3	1.06e-04	7	335	3	CID009547999
Drug	Azumoleno	RYR1 RYR2 RYR3	1.06e-04	7	335	3	CID000056259
Drug	mag-indo-1	RYR1 RYR3 MPG	1.06e-04	7	335	3	CID000131881
Drug	Br2BAPTA	RYR1 RYR2 RYR3	1.06e-04	7	335	3	CID003081001
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	PDE3B LPCAT4 SEMA4C SBF1 ANGEL2 DNMBP WASF1 HAUS5 MYOF PCSK6 ATP2A3	1.25e-04	190	335	11	5586_DN
Drug	propofol	GABRB1 GABRB3 GABRD RYR1 RYR2 RYR3 CHRNE TRPV3 TRAPPC9 LCT AASS	1.31e-04	191	335	11	CID000004943
Drug	Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A	EMC1 RIPK2 FBXO38 ANGEL2 ZNF589 EPN1 PODXL YTHDC2 ERN2 CES3 ATP2A3	1.31e-04	191	335	11	5607_DN
Drug	Labetalol hydrochloride [32780-64-6]; Down 200; 11uM; MCF7; HT_HG-U133A	EMC1 ANGEL2 ZNF589 PXN THAP3 EPM2A ANGEL1 YTHDC2 TEP1 MYOF PCSK6	1.37e-04	192	335	11	6809_DN
Drug	AC1L1IZE	RYR1 RYR2 RYR3 DNAH5 DNAH8 DNAH1 DNAH17 ATP2A1 ATP2A3	1.42e-04	131	335	9	CID000004799
Drug	Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A	PDE3B SRC RYR2 PTPN6 ZNF589 KAZALD1 TRAPPC9 DOCK1 HAUS5 ZFPL1 TTC33	1.50e-04	194	335	11	6779_DN
Drug	Finasteride [98319-26-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A	SPTBN2 SRC RYR1 CHRNE THAP3 SYT2 ZNF446 PCSK6 LRRC1 CES3 ACSL5	1.50e-04	194	335	11	3641_UP
Drug	Ipratropium bromide [22254-24-6]; Up 200; 9.8uM; HL60; HG-U133A	RIN3 UNC5B LAMC3 FARP2 COL10A1 DLGAP4 HAUS5 ARHGEF15 ELMO2 PHF3 NINL	1.50e-04	194	335	11	1769_UP
Drug	Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; PC3; HT_HG-U133A	LAMC3 CTIF FBXO38 PXN EPN1 YTHDC2 ARMC9 CDC14B RGS14 CD22 ELMO2	1.57e-04	195	335	11	3669_DN
Drug	AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A	RIN3 PDE6B CTIF ZZEF1 CIITA PXN ERN2 LDLR CLMN LRP1 STX6	1.57e-04	195	335	11	6440_DN
Drug	Bromperidol [10457-90-6]; Down 200; 9.6uM; HL60; HG-U133A	PDE3B EMC1 ATG2A LRIG2 ZNF589 HSPA4 ARHGEF15 MYOF STX6 ACSL5 ATP6V0A2	1.57e-04	195	335	11	1723_DN
Drug	Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; PC3; HT_HG-U133A	EMC1 MRM1 GART PRPF6 PRKD3 PXN HSPA4 FLII LDLR ELMO2 STX6	1.57e-04	195	335	11	3663_DN
Drug	Dihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; MCF7; HT_HG-U133A	PDE3B ACACB PDE6B SRC LPCAT4 SBF1 DSC3 THOC5 ZNF557 MYOF IGFALS	1.57e-04	195	335	11	7034_UP
Drug	Benzathine benzylpenicillin [5928-84-7]; Up 200; 4.2uM; HL60; HT_HG-U133A	NES SRC ZZEF1 INKA2 RYR2 SEMA4C COL14A1 GALNT10 DLGAP4 ERN2 MYOF	1.64e-04	196	335	11	2939_UP
Drug	estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A	PDE6B LPCAT4 CLIP1 ANGEL2 ZNF589 KAZALD1 TRIOBP GALNT12 IRGQ ZNF446 CLMN	1.64e-04	196	335	11	5205_DN
Drug	Propylthiouracil [51-52-5]; Up 200; 23.4uM; MCF7; HT_HG-U133A	RABEP2 TRAPPC9 DMXL2 DLGAP4 TEP1 ZNF446 TENM4 CD22 PRF1 CD70 GAST	1.64e-04	196	335	11	2837_UP
Drug	Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	LPCAT4 IRF2 FARP2 SBF1 ZNF589 PXN EPM2A RNF31 ARMC9 ERN2 CEP152	1.64e-04	196	335	11	5341_UP
Drug	S-(+)-ibuprofen [51146-56-6]; Down 200; 19.4uM; MCF7; HT_HG-U133A	RIN3 LPCAT4 RYR2 SEMA4C PSME4 PIK3CD KAZALD1 HAUS5 UST LDLR MYOF	1.64e-04	196	335	11	6471_DN
Drug	Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ABCA3 SRC CLIP1 PRKD3 SBF1 CCDC22 PHF3 PCSK6 CEP152 ATP2A3 CBX8	1.64e-04	196	335	11	2889_DN
Drug	F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A	PDE3B ACACB FARP2 PRUNE2 DMXL2 GALNT12 SPTBN4 PLA2R1 CD22 PCSK6 CEP152	1.64e-04	196	335	11	6396_DN
Drug	Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; HL60; HT_HG-U133A	RABEP2 CNTN5 PRUNE2 DSC3 NPEPL1 CDC14B SPTBN4 MYOF PIEZO2 PCSK6 ADGRD2	1.64e-04	196	335	11	2381_UP
Drug	Deferoxamine mesylate [138-14-7]; Up 200; 6uM; PC3; HT_HG-U133A	KDM3A SRC RYR2 PXN SARDH NPTX2 ERN2 UST CD22 ELMO2 ADGRD2	1.64e-04	196	335	11	4317_UP
Drug	Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A	MRM1 SRC LPCAT4 IMPACT MGAT2 PXN DNMBP RNF31 CDC14B PCSK6 PCIF1	1.71e-04	197	335	11	3573_DN
Drug	Propylthiouracil [51-52-5]; Down 200; 23.4uM; MCF7; HT_HG-U133A	PDE3B GPAA1 ATG2A KAZALD1 HERC6 IQCE EPM2A HAUS5 ABCC5 CDC14B TTC33	1.71e-04	197	335	11	2837_DN
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; PC3; HT_HG-U133A	FBXL18 PXN COL14A1 EPN1 PRUNE2 EPM2A ERN2 RGS14 CD22 PCSK6 LRP1	1.71e-04	197	335	11	4266_UP
Drug	Podophyllotoxin [518-28-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ACACB FARP2 FBXO38 ANGEL2 KAZALD1 HERC6 ERN2 SLC5A5 TGFBR3 PCSK6 LSS	1.71e-04	197	335	11	6103_DN
Drug	Vigabatrin [60643-86-9]; Down 200; 31uM; MCF7; HT_HG-U133A	PDE6B UNC5B SRC FBXO38 KAZALD1 VLDLR ERN2 ZFPL1 PRF1 DNAH17 LSS	1.71e-04	197	335	11	5415_DN
Drug	Tamoxifen citrate [54965-24-1]; Down 200; 7uM; MCF7; HT_HG-U133A	MGAT2 SBF1 KAZALD1 LRP5L ERN2 ZFPL1 MYOF CD22 PHF3 LSS CBX8	1.71e-04	197	335	11	6768_DN
Drug	Proxyphylline [603-00-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A	PDE6B MRM1 GART RYR2 CDC16 HSPA4 RNF31 ERN2 ZFPL1 ZNF557 STX6	1.71e-04	197	335	11	6494_DN
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A	PDE6B SPTBN2 FARP2 SBF1 KAZALD1 EPM2A ECH1 CD22 PRF1 PCSK6 ATP2A3	1.71e-04	197	335	11	5600_DN
Drug	Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; HL60; HT_HG-U133A	EMC1 UNC5B DDN RXRA SBF1 GALNT10 ANGEL1 ARMC9 TEP1 ERN2 PCIF1	1.71e-04	197	335	11	2526_DN
Drug	Methyldopa (L,-) [555-30-6]; Up 200; 19uM; MCF7; HT_HG-U133A	PDE3B PDE6B IMPACT LAMC3 CTIF ZNF589 LRP5L PDZRN4 ARHGEF15 AASS PCSK6	1.71e-04	197	335	11	3234_UP
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A	RABEP2 RELN PDE6B INKA2 PSME4 ZNF589 PXN THAP3 EPN1 NPTX2 ERN2	1.71e-04	197	335	11	3622_DN
Drug	Vitexin [3681-93-4]; Up 200; 9.2uM; HL60; HT_HG-U133A	RABEP2 ACACB MAP6D1 SRC FBXL18 ANGEL2 FLII COL10A1 UST MYOF STX6	1.79e-04	198	335	11	2155_UP
Drug	Levocabastine hydrochloride [79547-78-7]; Up 200; 8.8uM; HL60; HT_HG-U133A	CTIF FBXL18 SBF1 MTCL1 ERN2 CSF3R PCSK6 LPO PCIF1 CD70 LSS	1.79e-04	198	335	11	2948_UP
Drug	Sulfachloropyridazine [80-32-0]; Down 200; 14uM; MCF7; HT_HG-U133A	SPTBN2 LPCAT4 PRKD3 KAZALD1 THAP3 HERC6 DSC3 DLGAP4 POU4F1 CLMN LSS	1.79e-04	198	335	11	6046_DN
Drug	Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A	UNC5B PXN KAZALD1 HERC6 POU4F1 ERN2 MYOF PHF3 PRF1 PCSK6 CES3	1.79e-04	198	335	11	6083_DN
Drug	CP-944629 [668990-94-1]; Up 200; 10uM; MCF7; HT_HG-U133A	PDE3B EMC1 SRC LRP5L TUT4 YTHDC2 ERN2 PIEZO2 LSS CEP152 CBX8	1.79e-04	198	335	11	7544_UP
Drug	2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A	PDE3B SRC SBF1 ANGEL2 PXN ZNF446 CLMN LRRC1 PCIF1 LSS STX6	1.79e-04	198	335	11	5582_DN
Drug	Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A	EPPK1 TMEM94 LRFN3 LPCAT4 FBXL18 SBF1 KAZALD1 DNMBP ARHGEF6 HAUS5 TRIOBP	1.79e-04	198	335	11	7235_DN
Drug	Fenofibrate [49562-28-9]; Down 200; 11uM; HL60; HT_HG-U133A	RABEP2 MAP6D1 RIPK2 DDN CTIF FBXL18 ZNF589 HSPA4 IRGQ RGS14 PCSK6	1.79e-04	198	335	11	2401_DN
Drug	Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; PC3; HT_HG-U133A	EPPK1 MAP6D1 LPCAT4 HSPA4 TRAPPC9 DYNC1I1 ERN2 ZFPL1 CD22 ELMO2 PHF3	1.79e-04	198	335	11	5813_DN
Drug	Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; PC3; HT_HG-U133A	RIN3 UNC5B CTIF SEMA4C LRP5L TRAPPC9 TEP1 UST ZFPL1 TENM4 PCSK6	1.79e-04	198	335	11	3785_DN
Drug	Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; PC3; HT_HG-U133A	FBXO40 RIN3 MGAT2 KAZALD1 IDUA ERN2 SLC5A5 MYOF ELMO2 DNAH17 CBX8	1.79e-04	198	335	11	6354_UP
Drug	Flunixin meglumine [42461-84-7]; Up 200; 8.2uM; PC3; HT_HG-U133A	GABRB3 SPTBN2 PXN COL14A1 EPN1 CASS4 ZFPL1 CD22 LRP1 LSS ADGRD2	1.79e-04	198	335	11	4273_UP
Drug	Carbachol [51-83-2]; Down 200; 21.8uM; PC3; HT_HG-U133A	RABEP2 RIN3 ABCA3 EPPK1 ZZEF1 ZNF589 CASS4 NPEPL1 ARHGAP6 LRP1 CD70	1.79e-04	198	335	11	6742_DN
Drug	diclofenac sodium; Up 200; 10uM; MCF7; HG-U133A	NES MAP6D1 HAO1 CIITA PIK3CD ARHGEF6 MPPED1 ZFPL1 PIEZO2 DNAJC17 CBX8	1.79e-04	198	335	11	333_UP
Drug	Mephenesin [59-47-2]; Down 200; 22uM; MCF7; HT_HG-U133A	PDE3B CTIF RYR2 FARP2 FBXL18 ZNF589 COL14A1 DSC3 ERN2 MYOF AASS	1.79e-04	198	335	11	4698_DN
Drug	Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; HL60; HT_HG-U133A	CIITA COL14A1 DNAJC1 PRUNE2 ACTR8 COL10A1 DLGAP4 THOC5 RGS14 CEP152 TMEM140	1.79e-04	198	335	11	2999_DN
Drug	Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; MCF7; HT_HG-U133A	RELN ACACB UNC5B RYR2 COL14A1 CNTFR COMP LDLR ZFPL1 RGS14 LSS	1.79e-04	198	335	11	6496_UP
Drug	Xamoterol hemifumarate [73210-73-8]; Up 200; 5uM; MCF7; HT_HG-U133A	MRM1 LPCAT4 FBXO38 ZNF589 LRP5L HERC6 FLII RGS14 MYOF CD22 CEP152	1.79e-04	198	335	11	5363_UP
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR2 RYR3	1.41e-06	3	332	3	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR2 RYR3	1.41e-06	3	332	3	DOID:8545 (implicated_via_orthology)
Disease	polycystic liver disease (implicated_via_orthology)	PKD1 LRP5L LRP5	4.78e-05	7	332	3	DOID:0050770 (implicated_via_orthology)
Disease	X-21319 measurement	ACSM2A ACSM2B	1.26e-04	2	332	2	EFO_0800807
Disease	osteoporosis-pseudoglioma syndrome (implicated_via_orthology)	LRP5L LRP5	1.26e-04	2	332	2	DOID:0060849 (implicated_via_orthology)
Disease	adiponectin measurement	KNTC1 PDE3B CLIP1 LINC00528 PTPRK CNTN5 HCRTR1 ATP6V0A2	2.59e-04	146	332	8	EFO_0004502
Disease	autistic disorder (is_marker_for)	GABRB1 RELN VLDLR	2.88e-04	12	332	3	DOID:12849 (is_marker_for)
Disease	Brody myopathy (implicated_via_orthology)	ATP2A1 ATP2A3	3.76e-04	3	332	2	DOID:0050692 (implicated_via_orthology)
Disease	X-11478 measurement	ACSM2A ACSM2B	3.76e-04	3	332	2	EFO_0021242
Disease	Seckel syndrome 1	ATR CEP152	3.76e-04	3	332	2	C4551474
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	PKD1 LRP5L LRP5	4.69e-04	14	332	3	DOID:898 (implicated_via_orthology)
Disease	autosomal dominant polycystic kidney disease (is_implicated_in)	PKD1 LRP5	7.46e-04	4	332	2	DOID:898 (is_implicated_in)
Disease	spinocerebellar ataxia type 5 (implicated_via_orthology)	SPTBN2 SPTBN4	7.46e-04	4	332	2	DOID:0050882 (implicated_via_orthology)
Disease	Familial hemophagocytic lymphohistiocytosis	UNC13D PRF1	7.46e-04	4	332	2	cv:C0272199
Disease	Charcot-Marie-Tooth disease type 4H (implicated_via_orthology)	FGD3 FGD2	7.46e-04	4	332	2	DOID:0110192 (implicated_via_orthology)
Disease	prostate carcinoma in situ (biomarker_via_orthology)	RXRA LRP1	7.46e-04	4	332	2	DOID:8634 (biomarker_via_orthology)
Disease	X-linked Aarskog syndrome (implicated_via_orthology)	FGD3 FGD2	7.46e-04	4	332	2	DOID:6683 (implicated_via_orthology)
Disease	congenital stationary night blindness (is_implicated_in)	TRPV3 TRPM1	7.46e-04	4	332	2	DOID:0050534 (is_implicated_in)
Disease	heart disease (implicated_via_orthology)	RYR2 PIK3CD ATP2A1 ATP2A3	8.59e-04	38	332	4	DOID:114 (implicated_via_orthology)
Disease	Q Fever	LDLR LSS	1.23e-03	5	332	2	C0034362
Disease	Familial Hemophagocytic Lymphocytosis	UNC13D PRF1	1.23e-03	5	332	2	C0272199
Disease	filarial elephantiasis	HLA-DOB ERN2	1.23e-03	5	332	2	EFO_0007272
Disease	Coxiella burnetii Infection	LDLR LSS	1.23e-03	5	332	2	C2973787
Disease	Acute Q fever	LDLR LSS	1.23e-03	5	332	2	C0519066
Disease	Chronic Q Fever	LDLR LSS	1.23e-03	5	332	2	C1443892
Disease	3-hydroxyhexanoate measurement	ACSM2A ACSM2B	1.23e-03	5	332	2	EFO_0800378
Disease	Varicose veins	UNC5B MOB2 GJD3 WNT9B TGFBR3 ARHGAP6 TMEM87B PCSK6	1.61e-03	193	332	8	HP_0002619
Disease	indoleacetoylcarnitine measurement	ACSM2A ACSM2B	1.84e-03	6	332	2	EFO_0800106
Disease	nonsyndromic deafness (implicated_via_orthology)	LRP5L LRP5	1.84e-03	6	332	2	DOID:0050563 (implicated_via_orthology)
Disease	tendinitis (biomarker_via_orthology)	LRP5L LRP5	1.84e-03	6	332	2	DOID:971 (biomarker_via_orthology)
Disease	major depressive episode	PEAK3 CNTN5 FREM3 TENM4	1.92e-03	47	332	4	EFO_0007634
Disease	adult onset asthma	HLA-DOB UNC13D D2HGDH WDR36 TBL1XR1 LRP1	2.23e-03	118	332	6	EFO_1002011
Disease	Charcot-Marie-Tooth disease (implicated_via_orthology)	AARS2 FGD3 FGD2	2.40e-03	24	332	3	DOID:10595 (implicated_via_orthology)
Disease	trans fatty acid measurement, trans/trans-18:2 fatty acid measurement	INTU RYR3 CNTN5	2.40e-03	24	332	3	EFO_0006821, EFO_0006826
Disease	colorectal cancer (is_implicated_in)	SRC BCOR PIK3CD BUB1B TRPV3 GALNT12	2.52e-03	121	332	6	DOID:9256 (is_implicated_in)
Disease	asthma, Eczema, allergic rhinitis	TRMT10C PTPRK D2HGDH WDR36 RGS14 TTC33	2.52e-03	121	332	6	EFO_0005854, HP_0000964, MONDO_0004979
Disease	osteonecrosis (biomarker_via_orthology)	LRP5L LRP5	2.55e-03	7	332	2	DOID:10159 (biomarker_via_orthology)
Disease	Colorectal Carcinoma	ABCA3 SPTBN2 SRC BUB1B NCR1 DNAH8 NLRP8 PDZRN4 ABCC5 GALNT12 ABCC6 SLC22A9 LRP1 LAS1L TMEM140 MUTYH ACSL5	2.74e-03	702	332	17	C0009402
Disease	Autism Spectrum Disorders	GABRB3 RELN LAMC3 RYR2 USH2A	2.75e-03	85	332	5	C1510586
Disease	monokine induced by gamma interferon measurement	RIN3 UMODL1 LRP5L TMEM87B	2.79e-03	52	332	4	EFO_0008236
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	ACACB LDLR PCSK6 PCIF1 ATP4A	2.90e-03	86	332	5	EFO_0008595, EFO_0020945
Disease	Autistic Disorder	GABRB1 GABRB3 DOCK4 FBXO40 RELN FARP2 VLDLR TBL1XR1 PRF1	2.96e-03	261	332	9	C0004352
Disease	inflammatory biomarker measurement	VLDLR PIEZO2 PCSK6	3.03e-03	26	332	3	EFO_0004872
Disease	Embryonal Rhabdomyosarcoma	BCOR BUB1B	3.38e-03	8	332	2	C0206656
Disease	benign neoplasm (implicated_via_orthology)	LRRC1 SCRIB	3.38e-03	8	332	2	DOID:0060072 (implicated_via_orthology)
Disease	exudative vitreoretinopathy (implicated_via_orthology)	LRP5L LRP5	3.38e-03	8	332	2	DOID:0050535 (implicated_via_orthology)
Disease	response to beta blocker, heart rate	GABRB3 FMN1 TMEM131L DNAH17	3.89e-03	57	332	4	EFO_0004326, EFO_0007766
Disease	Colon Carcinoma	SRC MUTYH	4.31e-03	9	332	2	C0699790
Disease	isovalerate measurement	USH2A NPTX2	4.31e-03	9	332	2	EFO_0021051
Disease	severe acute respiratory syndrome, COVID-19	RELN RIN3 HAO1 FBXO47 PTPN4 PXN TRPM1 LRP5L TGFBR3 ARHGAP6 PCSK6 STX6	5.05e-03	447	332	12	EFO_0000694, MONDO_0100096
Disease	familial hypercholesterolemia (is_implicated_in)	LDLR MTTP	5.35e-03	10	332	2	DOID:13810 (is_implicated_in)
Disease	estrogen measurement	SLC22A25 SLC22A9	5.35e-03	10	332	2	EFO_0011007
Disease	adult onset asthma, body mass index	UNC13D TBL1XR1	5.35e-03	10	332	2	EFO_0004340, EFO_1002011
Disease	platelet component distribution width	RIN3 HLA-DOB ZZEF1 CHRNE ZNF490 NYNRIN CNTN5 GJD3 TMEM131L FGD3 IQCE PRUNE2 CFAP73 NELFCD ABCC5 ZNF496 ARHGEF15	5.62e-03	755	332	17	EFO_0007984
Disease	carcinoma (implicated_via_orthology)	SRC YES1 LRRC1 SCRIB	5.89e-03	64	332	4	DOID:305 (implicated_via_orthology)
Disease	salicylate measurement	MTTP ACSM2A	6.49e-03	11	332	2	EFO_0021161
Disease	kidney cancer (implicated_via_orthology)	LRRC1 SCRIB	6.49e-03	11	332	2	DOID:263 (implicated_via_orthology)
Disease	Abdominal Aortic Aneurysm	LDLR USHBP1 PCIF1 LRP1	7.28e-03	68	332	4	EFO_0004214
Disease	colon cancer (is_implicated_in)	KDM3A ATR SRC	7.66e-03	36	332	3	DOID:219 (is_implicated_in)
Disease	susceptibility to mononucleosis measurement	RYR2 DNAH8 WDR36 DNAH2	7.67e-03	69	332	4	EFO_0008403
Disease	Night blindness, congenital stationary, type 1	PDE6B TRPM1	7.73e-03	12	332	2	C3501847
Disease	Night Blindness, Congenital Stationary, Type 1A	PDE6B TRPM1	7.73e-03	12	332	2	C3495587
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)	PDE6B TRPM1	7.73e-03	12	332	2	C1864877
Disease	Gastrointestinal Diseases	KEAP1 GAST	7.73e-03	12	332	2	C0017178
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	PDE6B TRPM1	7.73e-03	12	332	2	C1850362
Disease	X-Linked Csnb	PDE6B TRPM1	7.73e-03	12	332	2	C3711543
Disease	dementia (is_implicated_in)	LRP8 VLDLR	7.73e-03	12	332	2	DOID:1307 (is_implicated_in)
Disease	Functional Gastrointestinal Disorders	KEAP1 GAST	7.73e-03	12	332	2	C0559031
Disease	Cholera Infantum	KEAP1 GAST	7.73e-03	12	332	2	C1565321
Disease	waist-hip ratio, body mass index	MRM1 KEAP1	7.73e-03	12	332	2	EFO_0004340, EFO_0004343
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	PDE6B TRPM1	7.73e-03	12	332	2	C1848172
Disease	stomach carcinoma (is_implicated_in)	BCOR MUTYH	7.73e-03	12	332	2	DOID:5517 (is_implicated_in)
Disease	fibrinogen measurement	DCHS2 FARP2 ZNF251 PARP10 TTC17	7.89e-03	109	332	5	EFO_0004623
Disease	cortical thickness	INTU RELN RIN3 DCDC1 FAM178B SPTBN2 LAMC3 LRP8 LRRIQ1 UMODL1 PKD1 MTCL1 MIEF2 PDZRN4 FLII TRIOBP GALNT12 SYT2 IDUA LRP1 CBX8 STX6	7.99e-03	1113	332	22	EFO_0004840
Disease	Combined oxidative phosphorylation deficiency	TRMT10C AARS2 TARS2	8.27e-03	37	332	3	cv:C4540031
Disease	autism spectrum disorder	PFAS ARHGEF6 MPPED1 GALNT10 GALNT12 CITED1	8.62e-03	156	332	6	EFO_0003756
Disease	Cone-rod synaptic disorder, congenital nonprogressive	PDE6B TRPM1	9.07e-03	13	332	2	C4041558
Disease	Connective Tissue Diseases	PKD1 PIEZO2	9.07e-03	13	332	2	C0009782
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	DMXL2 TRIOBP	9.07e-03	13	332	2	C1846647
Disease	Moyamoya disease	PLOD1 DOCK1 LRP1	1.03e-02	40	332	3	MONDO_0016820
Disease	Disorder of eye	PDE6B PRPF6 BCOR TRPM1 USH2A MTTP LRP5	1.05e-02	212	332	7	C0015397
Disease	tetralogy of Fallot (implicated_via_orthology)	DNAH5 DOCK1	1.05e-02	14	332	2	DOID:6419 (implicated_via_orthology)
Disease	cardiotoxicity, response to anthracycline-based chemotherapy	PRUNE2 POLRMT	1.05e-02	14	332	2	EFO_0005257, EFO_1001482
Disease	kidney disease (implicated_via_orthology)	SRC LCT YES1	1.10e-02	41	332	3	DOID:557 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
ETLLNPTWLRNEDSG	UMODL1	666	Q5DID0
VGRAWDPEKLAQELA	USHBP1	581	Q8N6Y0
EWELSKENVQPLRQG	BUB1B	21	O60566
LDQWSQLEKDGLRGP	ACSM6	56	Q6P461
AQLGDLPWQVAIKDA	CFI	346	P05156
NAHQRWLGELPELAE	CEP152	861	O94986
ELQPEQVAELWGRGD	EGFL8	246	Q99944
QLELQILSEPIQAWE	ARHGEF6	426	Q15052
SLDNRNWPLEVLVTD	CASS4	536	Q9NQ75
INLNDIEKVLPAWQG	CTIF	156	O43310
ELATPDWAERQLAQG	CIITA	381	P33076
AENGDLNWIIPDRFI	CDC14B	211	O60729
WLLREGLNKPESNEQ	ACTR8	91	Q9H981
LNWAEAECKRQGLPI	BTBD6	306	Q96KE9
QPWPERLSNNVEELL	ACRBP	166	Q8NEB7
LLPETLENWRAQTGL	ACSM2A	341	Q08AH3
ALIANGDELVAAVWP	ATP13A1	41	Q9HD20
ESQVRLLWKDPRNVG	COMP	661	P49747
AAEWLGLLGDEQVPQ	AASS	796	Q9UDR5
GAVSPELLWQLLQRS	BTBD17	206	A6NE02
GEAIWVAENLAQPLT	LINC00528	151	Q8N1L1
GIQWRDLLSPVNVDD	ABCA3	431	Q99758
DALGPLQRAFWLDVS	IGFALS	476	P35858
DLVILDGIPTAGWLQ	DNMBP	91	Q6XZF7
LLEEEQWSLSPDLRQ	CCDC142	616	Q17RM4
NPEVLEQWRVQTGLE	ACSM4	351	P0C7M7
WQELPAVQASGLLDT	ARHGEF15	396	O94989
LAWDPQDNRLLTATD	DMXL2	116	Q8TDJ6
PLGIAVIKNLENWEQ	DMXL2	2541	Q8TDJ6
QLQVIALGSEAWDPV	DNHD1	4121	Q96M86
SLLTEQDLWTVNGLP	ANGEL2	511	Q5VTE6
PIQARDLGELLQAWG	CCDC22	266	O60826
PIWLDDILCQGNELA	CD163L1	216	Q9NR16
QQLRDAWPDEVLAQG	CFAP73	196	A6NFT4
LQEATNWRAGPLAEV	DDN	91	O94850
VAQGPRNWLLLSDVL	BCOR	1656	Q6W2J9
AENGDLNWIIPDRFI	CDC14C	181	A4D256
DDILINGLPDWRQPV	DNAJC1	126	Q96KC8
QQLPLESLGWDVAEL	CD70	46	P32970
PTAQDLAGFWDLLQL	DLGAP4	876	Q9Y2H0
ELEALAQQVPGLQRW	EFCC1	301	Q9HA90
QLLWVNLVTDGLPAT	ATP2A1	791	O14983
QLLWVNLVTDGLPAT	ATP2A3	791	Q93084
PLGAEDLWLIEQDLN	ATG2A	321	Q2TAZ0
VPWGSLLQDNCALEV	ATG2B	81	Q96BY7
WLPEIVLENNIDGQF	CHRNE	106	Q04844
QLLRGKQDGSEWVVP	CECR9	191	P0C854
LNDTQLDSGSPLRWE	CNTN5	396	O94779
KDNDGRLDPQELLPW	RCN2	241	Q14257
DRNQALLVPALGESW	RAD51C	291	O43502
GPEALLQVWAAESAL	RCCD1	91	A6NED2
LQVWAAESALRGEPL	RCCD1	96	A6NED2
LLVARPEIQLDEGWL	PDZRN4	481	Q6ZMN7
LVPDTQWEQLQTEGR	RABEP2	286	Q9H5N1
ENLDLWAGPLHISVQ	TSPOAP1	846	O95153
EPGWERLEQRAATLQ	TSPOAP1	956	O95153
RTRPNLWVLEEKGNL	FMN1	206	Q68DA7
LWVLEEKGNLLPNGA	FMN1	211	Q68DA7
WLEEQINSNTIPGLK	IRF2	11	P14316
LAEKRPDASWVINGL	IQCE	201	Q6IPM2
LQSRLKEQLEWQLGP	MTCL1	936	Q9Y4B5
KEQLEWQLGPARGDE	MTCL1	941	Q9Y4B5
GLQLADDSTDNPRWL	PTPN4	71	P29074
LNGAPELAADWLNRR	INO80	1051	Q9ULG1
LPREIDLNEWLASNT	MOB2	46	Q70IA6
WTEDDLQQGKRISVP	ACACB	411	O00763
VSLLDWINVQDRPND	RB1CC1	306	Q8TDY2
KPILQAWLEEAEGAQ	POU4F1	326	Q01851
NGELGDSWIVPLDNL	PODXL	531	O00592
GQLNEEFDWPIQGLL	DCDC1	901	M0R2J8
ALALQEPGLWLGEVE	EPM2A	51	O95278
SPTEQDGRQLWLEVK	KIAA0100	1641	Q14667
TLLVQGQELPEFWEA	FLII	691	Q13045
ASIEWRKDGLDIQLP	KAZALD1	201	Q96I82
GEPRKLLTQDWVQEN	MAGEA4	241	P43358
LRILSNEPWELENPV	MAGED4	66	Q96JG8
TVDLPIENQLLWQID	HSPA4	576	P34932
WLQVAGLSEEQLQEP	LPCAT4	66	Q643R3
LTANLEAQALWKEPG	LGALS3BP	176	Q08380
RVGELWSEPSNLLDL	NCR1	101	O76036
LLAEWLIQTGVEPVQ	NELFCD	96	Q8IXH7
ELQEAPLSLAEGWQL	GPAA1	566	O43292
VFADLVGNWLDLPEL	INKA2	161	Q9NTI7
NVDKAGTWAPRELVL	MGAT2	106	Q10469
QLAKLDSEAWPGVLD	WWC1	321	Q8IX03
DLSEDWRQKLPGSVL	NLRP8	301	Q86W28
TWDLLRLPLEREQNG	GPSM1	416	Q86YR5
EANVNWLPPLLDRIA	GALNT10	241	Q86SR1
RETLVQDNIQWPTGL	LRP1	4036	Q07954
RLAVQLPPGEDLNDW	MOB3A	46	Q96BX8
RKGLANVQWSGDEPL	ARMC9	636	Q7Z3E5
QTGDLKWTLRDDPVI	ERN2	56	Q76MJ5
NDPDGIAVDWVARNL	LRP5	416	O75197
RLDLWNLNNDTEVPT	DYNC1I1	556	O14576
IWDLLQSDLGPVAKQ	DYNC2I1	981	Q8WVS4
GDLANIQALPKAWDR	C1orf109	166	Q9NX04
LGPWTELRQEEILVD	FAM135A	676	Q9P2D6
EKAEGQWTLEIQDLP	PCSK6	596	P29122
LLPNLRAVGWNELEG	PCBD1	16	P61457
INLLGKELADWDATP	KIAA1586	736	Q9HCI6
SNVDVALLWRNPDGD	MTTP	61	P55157
ALLWRNPDGDDDQLI	MTTP	66	P55157
GKLQPRVTEELWQAA	NPEPL1	41	Q8NDH3
AGLLPGQWLEAEEDN	PDE3B	1006	Q13370
LLATGGPLRLQVWDQ	PRF1	471	P14222
NIDIWIGAIAEPLVE	LPO	606	P22079
EAWGAALVELRPENL	PEAK3	296	Q6ZS72
WEQGDLERTVLDQQP	PDE6B	741	P35913
LILDGPVDAIWIENL	DNAH8	2201	Q96JB1
DILQPKGDDVARISW	ECH1	126	Q13011
EEVAEAGPEALRWLQ	HAO1	116	Q9UJM8
WDQNDVDLIPNGISI	HERC6	831	Q8IVU3
IDWLAQRNNVAPDEL	LSS	271	P48449
AWILINPLRKEDEGV	IGFBPL1	226	Q8WX77
IPVVIDADGLWLVAQ	NAXD	176	Q8IW45
DADGLWLVAQQPALI	NAXD	181	Q8IW45
GAWNLENLRSPEEVD	NES	896	P48681
GQVPQLLLDPAAWDR	NES	1391	P48681
NPWREISGEAIDLIN	PRKD3	796	O94806
ALQDIGGWENPALID	LCT	1026	P09848
WGENPEIKRANLDRQ	LRP5L	96	A4QPB2
LAQEVNIPDWIVDLR	LAS1L	141	Q9Y4W2
LTDKANWPENGLQLA	KNTC1	636	P50748
AERLWLIAADNGNPK	LRP2BP	156	Q9P2M1
TLWRLDLAGNNIPGD	LRRC45	201	Q96CN5
LTLDNRVADQLWVPD	GABRB1	106	P18505
LTLDNRVADQLWVPD	GABRB3	106	P28472
LEISWLPNLDGLIAG	GABRD	36	O14764
LLDLDGQPVVERWIS	LRRC46	161	Q96FV0
NNLEQLPWEALGRLG	LRFN3	166	Q9BTN0
LPWEALGRLGNVNTL	LRFN3	171	Q9BTN0
QLDGETDWKLRLPVA	ATP9A	191	O75110
EWDTNPRLGDILQKL	FGD3	226	Q5JSP0
ALERIPELQGIVGDW	HAUS5	581	O94927
EQLLLDGPWRNESAL	CDC42BPB	11	Q9Y5S2
QALLEKWNLIPEGVD	MPPED1	226	O15442
QLNAPWLKGQERADL	IMPACT	71	Q9P2X3
VWRSEAALDDLQGLP	CRACDL	606	Q6NV74
DLWLDGNQLSELPQE	LRRC1	201	Q9BTT6
GNPLLQETNWRDSLL	LRRIQ1	1116	Q96JM4
WALDNILIGGAEINP	RELN	3041	P78509
APNLSKLVAEWEGQD	PLOD1	161	Q02809
LKGVRSDPLQQWELV	SBF1	1336	O95248
RLWQELSDSLGPVVQ	PASD1	691	Q8IV76
PNTGELINWVALDRE	DCHS2	1241	Q6V1P9
LEPEWLDSVQKNGEL	INTU	51	Q9ULD6
EALNGTILDPLDQWQ	PXN	56	P49023
QIWELLSTDNPDALP	ARHGAP6	956	O43182
QQPALAGADWQLLVE	PCTP	21	Q9UKL6
SLELQEVWIPKNGTR	FBXO38	606	Q6PIJ6
RLWQEELNEVGPDAA	ABCC5	151	O15440
RNWKRPSDQLGDLEQ	HCRTR1	256	O43613
TGANRDLELPWLEQQ	GAST	36	P01350
RLDFLQAWIQDGIPA	DNAH1	4096	Q9P2D7
QPLRDLIEKIGGWNI	EEF1AKMT4-ECE2	311	P0DPD8
QEIRQLELVEPSGWI	ANAPC10	106	Q9UM13
GNEVTVDKWEPLLNN	CDC16	436	Q13042
IIEWVNNTAGLRPIL	ATR	2376	Q13535
IQDPDGSWAQIAEKR	IGSF8	276	Q969P0
GDQWNILQTPILEGR	KLHL14	546	Q9P2G3
DNEAIGLWLPLTKNV	KDM3A	596	Q9Y4C1
TWEPEENILDARLLA	CBX8	41	Q9HC52
EQLEALPGLVWDLGQ	DACT3	81	Q96B18
WGTSPEDKQQAALLR	PCIF1	156	Q9H4Z3
QPDAEQWNSRLDLLE	HLA-DOB	81	P13765
DLIAWQIPFLAEGIR	DOCK1	1566	Q14185
DWGNEQLGLDLVPRK	DOCK4	151	Q8N1I0
IPIEDKDLINTANWR	DSC3	376	Q14574
ILGNTERWPLIVDAQ	DNAH17	3431	Q9UFH2
AIEWPGANAQLLEID	ELMO2	11	Q96JJ3
ALLQAWGSAEVPQRL	CD1D	11	P15813
LLQLPGDDGLNVEWL	FAM151A	331	Q8WW52
WEILNKNSDPLVGVI	COL14A1	1306	Q05707
TWRVNGTDLAPDLLN	CNTFR	56	P26992
SPKDVLVRWLQGSQE	IGHA1	256	P01876
PVLSLQQLEAWDLDD	DNAAF8	256	Q8IYS4
GWLEPLLQRIHEEES	GALNT12	236	Q8IXK2
LAQDEAVWLERGPLE	MPG	236	P29372
GIFAQNRPEWIISEL	ACSL5	136	Q9ULC5
LDAVQLQSPLVGRLW	GJD3	11	Q8N144
DPEPQILWRLGAELQ	CSF3R	56	Q99062
GLVDNPLKISWLEGQ	DNAJC17	236	Q9NVM6
IEENRIAPLAWINQE	ECM2	521	O94769
ALPLTQGQLVLVWSD	IDUA	556	P35475
GLAPWQDGVLERLKT	FBXO40	286	Q9UH90
WNQLDRSDVAVPLTL	MAP6D1	16	Q9H9H5
AWPQSSGEEELQLQL	EPN1	176	Q9Y6I3
ELSVVPREWLLENNA	FBXO47	311	Q5MNV8
QELQSEELGLRAPQW	FGD2	441	Q7Z6J4
NPSDGTWLRLADLQV	KEAP1	346	Q14145
NDIVGEAEPLSNWDR	DDX53	141	Q86TM3
QTLALETEWELRQIP	EMC1	246	Q8N766
ETEWELRQIPLQSLD	EMC1	251	Q8N766
PEVWAAGEQELLLLL	EME2	131	A4GXA9
ELQRWPEAAALIQEK	HELZ2	1836	Q9BYK8
DVVAALRWVQENIAP	CES3	201	Q6UWW8
EVEQRLALWEGPSKA	FARP2	596	O94887
NEPTWAEAKRQLGEQ	DNAH2	3136	Q9P225
NDSGAWLRATIPLDQ	SLC22A20P	61	A6NK97
ESARWLIINNKPEEG	SLC22A25	281	Q6T423
NLSKNGGLEVWLPRD	SLC22A6	56	Q4U2R8
ELPLDDQVILLRAGW	RXRA	291	P19793
DDVKGQWDRLVLNTP	RYR1	4696	P21817
PSEDDIKGQWDRLVI	RYR2	4621	Q92736
QAPESPWEEQLARLL	POLRMT	181	O00411
PWEEQLARLLQEAPG	POLRMT	186	O00411
SILIKGQELPLDEQW	ATP4A	531	P20648
AWEEPSLGVLKIQNV	CD22	461	P20273
QWAGIVLDEPIGKND	CLIP1	86	P30622
VLQWDRKLSELSEPG	CREB3L2	11	Q70SY1
DPEALQAPNVDWLRT	D2HGDH	81	Q8N465
ILDGPVDAIWIENLN	DNAH5	2336	Q8TE73
GAPTEKDWAQVQALL	IRGQ	306	Q8WZA9
KDWAQVQALLLPDAP	IRGQ	311	Q8WZA9
NILLWGNLPEIEEST	FAM72B	121	Q86X60
DNIEWPNGITLDLLS	LRP8	581	Q14114
QPERQFVQLGDEAWL	PKD1	1386	P98161
AWDPPQELQADAARL	PRSS56	351	P0CW18
NKLWLQRRNGEDIPV	PTPRK	226	Q15262
WNVGDQVLLLSLPRN	NYNRIN	1826	Q9P2P1
QLWRQEPDNTGVLLL	OGT	46	O15294
QTLKGPWNNLERLAE	PARP10	811	Q53GL7
PVWLQLSLGQAEVAR	RIN3	61	Q8TB24
ELPEGLRAEALWGVN	ITPRIPL2	336	Q3MIP1
AVPGVDADDRLLLAW	MIEF2	306	Q96C03
SLWLDPLRDLVIGVQ	FREM3	76	P0C091
EWAKALLQENSPLIG	RTL1	251	A6NKG5
NTVDLGQPIEEWRDL	SYT2	246	Q8N9I0
LGEWDLPEAVQRLVE	TARS2	691	Q9BW92
QKENGRALLLQWSEP	USH2A	4076	O75445
QGLAKDAWEIPRESL	SRC	256	P12931
ELAQPDTWLDAGAQV	SLC6A19	261	Q695T7
DWQNESKEGLAIPLR	TMEM26	341	Q6ZUK4
LKREGQTAEVPNLWS	SNX29	551	Q8TEQ0
QTAPDSLDLWNRVIL	PRUNE2	1106	Q8WUY3
SLPWGLTLTLEEQAQ	SSPOP	4881	A2VEC9
ALLWEAGNLTDLPNL	TMEM140	31	Q9NV12
LPNVVELWQAEEGEL	TMEM131L	46	A2VDJ0
ELWQAEEGELLLPTQ	TMEM131L	51	A2VDJ0
VWLGNEVELLENPVD	TMEM132B	946	Q14DG7
ENLAPWGELATDNII	TCAF2	656	A6NFQ2
WELPDLQEGKIQAIS	FAM78A	111	Q5JUQ0
ILPQADWIIVLANGA	ABCC6	816	O95255
EWLSIPEVGDARNKR	PRPF6	156	O94906
KSEDVWLEAARLQPG	PRPF6	341	O94906
ESARWLIINNKPEEG	SLC22A9	281	Q8IVM8
QTENQEVGWDLEPLI	FAM183A	86	A6NL82
DDPQQLWLVLDGIQD	MRM1	141	Q6IN84
LLWDLIVDGIFLQPD	FAM178B	346	Q8IXR5
QDITPDQWGELQLLC	FAM178B	611	Q8IXR5
AGVQWRDLSSLQPLL	FBXL18	766	Q96ME1
ALSQLAWELLGEPRA	GPR150	101	Q8NGU9
IPWEQAARLLEAQVA	EPPK1	1031	P58107
GENDAILEWPVENRQ	MEP1A	491	Q16819
AQGLFQRWTELLQDP	STX6	21	O43752
LVQRPNSGLLAGLWE	MUTYH	386	Q9UIF7
DTLGALPNLRELWLD	SCRIB	191	Q14160
ELWLDRNQLSALPPE	SCRIB	201	Q14160
LELQGAISWEAPVEK	SEMA4C	81	Q9C0C4
RAPLENLGLVWLAVV	SEMA4C	656	Q9C0C4
DELQAELEGLWARLP	NINL	566	Q9Y2I6
ANEIVLIEWGNNPIE	NPTX2	276	P47972
LIEWGNNPIELLIND	NPTX2	281	P47972
LEQQLWGVELLPSSL	PPP1R15B	176	Q5SWA1
ALTPERLLEWQDKGI	PLA2R1	26	Q13018
ARQAEPVQKQGLWLD	AARS2	481	Q5JTZ9
EVNAIKWDPTGNLLA	TBL1XR1	351	Q9BZK7
RVPSLDWEGLLELLQ	TRIOBP	1576	Q9H2D6
GLLWQLRPSDVEVEL	SARDH	111	Q9UL12
GPLLQWLEDRLEQNQ	BRCC3	281	P46736
DPELLLTGPWEQLSQ	ADGRD2	446	Q7Z7M1
LLPETLENWRAQTGL	ACSM2B	341	Q68CK6
LSEEILWAANGLPNP	ANGEL1	636	Q9UNK9
DGNPSLVLGLIWNII	CLMN	121	Q96JQ2
GLDRANELPELWLGQ	CITED1	166	Q99966
PLLDWERNFAAVLDG	CLNK	46	Q7Z7G1
IIDLTENDQVWLQLP	COL10A1	641	Q03692
WGRAELALSLLQETP	RNF31	656	Q96EP0
EPGEWALERAKLNVN	UST	261	Q9Y2C2
ILDGQWDEVLQFIQP	WDR47	56	O94967
LKTNAGPRDRELWVQ	UFC1	16	Q9Y3C8
DVILRLEQGKEPWLE	ZIM3	56	Q96PE6
FTLEEWALLDPGQRN	ZNF490	66	Q9ULM2
LVDQNGQLISDWIPK	TEP1	1271	Q99973
PREGRLISDINKAWE	SPTBN2	386	O15020
KEQWLNGLALPERLE	SPTBN2	871	O15020
SLWGLVSDVPQELQA	PROM2	196	Q8N271
APALILNQVTGLDIW	SLC5A5	151	Q92911
QDALRDGREIQWPSA	TMEM94	136	Q12767
GDATLKNPILWNVAD	RPN2	486	P04844
PSEDDIKGQWDRLVI	RYR3	4526	Q15413
EDGWAQETLLAPVRL	WDR97	136	A6NE52
ISLIESGWAQNPDER	RIPK2	266	O43353
LWLDQSPRGDNLLSV	SPOCD1	226	Q6ZMY3
RFQLGDPTLNALEIW	PFAS	541	O15067
NAWAPLQDLVIRGLA	TREH	466	O43280
LIRIWLQEPLVQDEG	PIEZO2	351	Q9H5I5
VKLEPELVEAWNQLG	TTC5	96	Q8N0Z6
RLINEDPGSWLNAIS	THUMPD2	96	Q9BTF0
VLIGWENQPTTLELA	PHF3	1446	Q92576
LWSLEQPFRIELIQG	PIK3CD	316	O00329
TLPIDNGLNLVEWRQ	TENM4	1801	Q6N022
PDWDALQLIVERLPQ	TMDD1	191	P0DPE3
DAWLTAQEPLLQSRE	SPTBN4	2061	Q9H254
DLANALIWPEIQQEL	ARHGAP31	646	Q2M1Z3
LSPVNIDRQAWLGEE	RGS14	131	O43566
IDRQAWLGEEVLAEP	RGS14	136	O43566
LALVDEFQQAWPLEG	TTC17	776	Q96AE7
SPTGVILDLWEALQQ	UNC5B	901	Q8IZJ1
DELIGLWVSVQNLPQ	PSME4	236	Q14997
EKLGVDLDAQTWRIP	GART	696	P22102
QVSPLDNGDLIREIW	PTPN6	396	P29350
DVRGNLPQDLSVWID	TOB1	81	P50616
PRIQEEWGLLDRSQK	ZNF446	206	Q9NWS9
APDQLSLALAWNRVD	TRPM1	371	Q7Z4N2
ETDPRKIELLNWVNA	TRPM1	446	Q7Z4N2
SLWVFALGQLEQPEI	TRGV11	11	A0A075B6L2
RGPLSVQEDWIKHLQ	ZNF644	1271	Q9H582
RAVPELGLWLETVND	TMEM87B	41	Q96K49
GEQLLQLWERLPLGE	YTHDC2	1411	Q9H6S0
KELWVLNLLGAEEPD	ZNF251	71	Q9BRH9
QEAAGPREALQRLWD	ZNF496	51	Q96IT1
LEQGEDPWIINAKIS	ZNF26	66	P17031
PDVAVSWGLDLQLLV	ZZEF1	1196	O43149
VDLALNVLPGLSTWQ	UGT2A3	91	Q6UWM9
WELETTRNNDGLTPL	TRPV3	331	Q8NET8
LQLAPLQWDVLVDGQ	TRAPPC9	1011	Q96Q05
AAELEPDQLLAWQGL	TTC37	66	Q6PGP7
RREWQKLAQGPELAE	WASF1	201	Q92558
PELLKEWVLNIGRGN	THAP3	31	Q8WTV1
RQWEEQGELLLPLTF	ZDHHC12	36	Q96GR4
EQLLGWTAEALPAKD	ZNF589	6	Q86UQ0
GDPHQQTLARLDWEL	THOC5	181	Q13769
ATNEALGRLELWAPA	WNT9B	251	O14905
QLQLHLARIPEWGQD	TGM7	491	Q96PF1
LGALIVDPLEAIQWE	TSPY26P	141	Q9H489
ADRVAQIIKDDLWPN	TSPY26P	306	Q9H489
TQEEWALLDPAQRTL	ZNF557	46	Q8N988
LPSLAVRDWLDASQQ	TRIM8	516	Q9BZR9
LETPNRVSLGQLWLE	TUT4	621	Q5TAX3
DDNDLYRWEVLIIGP	UBE2G1	31	P62253
TNSNPLIRELAWEGL	WDR87	931	Q6ZQQ6
QLLESEGWNRRNVDP	TRMT10C	226	Q7L0Y3
QHEELPGLDSQWRQI	USP11	71	P51784
PAQLAWEALEQRVGA	UNC13D	716	Q70J99
GLVDTRQKWAPLENR	WDR73	201	Q6P4I2
NWARAGLGLPLIDEV	ZFPL1	126	O95159
IRDDIPSTQGNLVKW	TGFBR3	316	Q03167
RLEQGEEPWVLDLQG	ZNF7	56	P17097
LGIDPIWNLATNRLT	ATP6V0A2	531	Q9Y487
QELRQGLLVWQQEEP	XKR8	101	Q9H6D3
QDLWPQLSLVIDGGQ	YRDC	211	Q86U90
NRNWEKELLPGQLDT	TTLL13	566	A6NNM8
REAIQKWDEALQLTP	TTC33	76	Q6PID6
KPNIRWNDVAGLEGA	VPS4A	121	Q9UN37
PLLVTNGADNALRIW	WDR36	346	Q8NI36
QTQGLAKDAWEIPRE	YES1	261	P07947
TADIQWPNGITLDLI	VLDLR	596	P98155
VTENIQWPNGITLDL	LDLR	556	P01130
LLPEAIWIQTGVQLA	BPIFA4P	156	Q86YQ2
PAQALNETQWALERL	LAMC3	1501	Q9Y6N6
RLNWTKDDGPLLVTE	LRIG2	726	O94898
TPEWVLQDLIIALQG	NLRP13	766	Q86W25
QLLLQRWKDPESGLD	NAALADL1	81	Q9UQQ1
WNEILEFDLRGIPLD	MYOF	46	Q9NZM1